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ABSTRACT 
Dentin and bone are composed of mineralized extracellular matrices (ECM) 
produced by their formative cells, odontoblasts and osteoblasts. A major component of 
their ECM is Collage Type 1, along with numerous non-collagenous proteins (NCPs). 
Dentin sialophosphoprotein (DSPP) is the major NCP of dentin. Belonging to the 
SIBLING (Small Integrin-binding ligand, N-linked Glycoprotein) family of proteins, 
DSPP is primarily associated with mineralized tissues. Expression of DSPP (protein and 
mRNA) has been reported in dentin, periodontium, alveolar bone, condylar cartilage and 
several non-mineralized tissues. Upon secretion, DSPP is cleaved into two fragments - 
dentin sialoprotein (DSP) from the N-terminal region and dentin phosphoprotein (DPP) 
from the C-terminal region. In humans, DSPP mutations have been linked to non-
syndromic inherited dentin diseases, dentinogenesis imperfecta (DGI) and dentin 
dysplasia (DD). DSPP deletion in mice results in formation of hypomineralized dentin. 
The dentin defects in the Dspp null mice closely resemble the dentin defects of human 
DGI type III, with widened predentin and irregular dentin mineralization. Although the 
role of DSPP is critical for the formation of dentin, its role in other hard tissues of the 
periodontium like alveolar bone and cementum is yet to be studied. Also, previous studies 
showed that the expression level of DSPP in the rat long bone is approximately 1/400th of 
that in the rat dentin, however, its role in long bone is not known. This dissertation is a 
comprehensive effort to outline the function of this protein and its cleaved fragments in 
periodontium and long bone formation. In the first study, we hypothesized that the 
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proteolytic cleavage of DSPP into its two fragments is essential to periodontal hard tissue 
formation. Transgenic mice expressing the uncleavable full-length DSPP but lacking 
endogenous Dspp had severe defects in alveolar bone and cementum. These results 
indicate that the proteolytic processing of DSPP is crucial for periodontal integrity. 
Previous studies have demonstrated that the NH2-terminal fragment of DSPP inhibits the 
formation and mineralization of dentin, while the role of this fragment in periodontium is 
unclear. In the second study, expressing only the NH2-terminal fragment with the lack 
endogenous Dspp exacerbated the periodontal defects of Dspp-null mice. This study 
indicates that the NH2-terminal fragment of DSPP may exert an inhibitory role in the 
formation and mineralization of hard tissues in the periodontium.   Previous reports 
showed that transgenic expression of DSPP completely rescued the dentin defects of 
Dmp1-null mice. To investigate if this is true for the long bone defects, we assessed the 
effects of transgenic DSPP overexpression on osteogenesis by analyzing the formation 
and mineralization of the long bones in Dmp1-null mice that expresses a transgene 
encoding full-length DSPP. The transgenic DSPP overexpression partially rescued the 
long bone phenotypic defects of Dmp1-null mice. Together, these studies shed new light 
on the significant function of DSPP in mineralized tissue formation.  
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CHAPTER I  
INTRODUCTION 
Mineralization in biological organisms is defined as the process by which these 
organisms produce minerals. The minerals are formed by normal cellular mechanisms that 
produce precisely organized structures in organisms ranging from bacteria and algae to 
bones in vertebrate animals [1, 2]. These biominerals provide support, and play significant 
roles in defense and feeding mechanisms. The development of endoskeletons improved 
mobility and mechanical stability in vertebrates. Bones and teeth protect the internal 
organs, enhance mobility, enable mastication and help organisms perform other functions. 
They also harbor a multitude of cells and growth factors that, in turn, control tissue 
properties [3]. Due to their significance, mineralized tissues are central subject of research 
and numerous studies have tried to understand the mechanisms and fundamental principles 
governing their development and regulation, and alleviating the disease process affecting 
these hard tissues.  
Mineralized tissues 
Mineralized tissues are complex structures consisting of an inorganic mineral 
phase, an organic phase, and cells. The cells secrete various factors that regulate these 
structures after formation and control the initial production of these tissues. Much of the 
vertebrate skeleton is made up of bone. Dentin, enamel and cementum are the other 
mineralized tissues in vertebrates and form the tooth. Study of the structure and 
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composition of these tissues may offer a comprehensive understanding of the 
mineralization process. 
Bone 
Long bones are made up of an outer cylinder of cortical bone which surrounds a 
marrow cavity that includes rods of trabecular bone. The organic extracellular matrix 
(ECM) of bone consists predominantly of a collagen (mostly type I + type III, traces of V, 
XII, XIV), and lesser amounts of other non-collagenous proteins (NCPs). Three different 
embryonic cell lineages make up the vertebrate skeleton. The craniofacial bones develop 
from the cranial neural crest cells, mesodermal cells give rise to the axial skeleton, and the 
limb skeleton arises from the lateral plate mesodermal cells. In the developing embryo, 
these cells migrate to where skeletal elements will develop, and differentiate into 
osteoblasts or chondroblasts to form bone and cartilage respectively [4]. The craniofacial 
skeleton forms by a process called intramembranous ossification as the neural crest cells 
directly differentiate into osteoblasts, whereas the remaining skeleton is formed by 
differentiation of the mesodermal cells into chondrocytes that produces a framework of 
cartilage of the future bones. The cartilage is subsequently replaced by bone through the 
process of endochondral ossification [5]. 
Tooth 
The tooth proper consists of a hard, inert, acellular enamel which is supported by 
the less mineralized, more resilient, and vital hard connective tissue dentin. Dentin is 
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formed from odontoblasts and supported by the dental pulp which, a soft connective tissue 
rich in blood vessels and nerve endings [6]. Tooth development starts with a local 
thickening of the oral ectoderm that induces condensation of the neural-crest-derived 
mesenchyme [7]. Tooth development progresses through a series of well-defined stages – 
epithelial thickening, bud, cap and bell and late bell stages. In mouse embryo, a thickening 
of the oral epithelium is first visible at around E11.5 (embryonic day 11.5). Further 
invagination of the oral epithelium into the underlying mesenchyme gives rise to the tooth 
bud. [8, 9]. During the cap stage, around E13.5, the mesenchyme surrounding the bud 
condenses and expresses a host of signaling molecules and transcription factors [10, 11]. 
At the tip of the bud, the dental mesenchyme signals and induces the formation of a 
structure known as the enamel knot. This knot of cells express a host of signaling 
molecules and are considered as an important signaling center for tooth development [12]. 
The enamel knot disappears during the transition to the bell stage with the tooth organ 
cells terminally differentiating. The inner enamel epithelial cells differentiate into 
ameloblasts and the dental pulp mesenchymal cells into odontoblasts. [13]. Starting at the 
cusp tips, differentiation of odontoblasts proceeds in a cervical direction [14]. At the onset 
of the late or advanced bell stage, signals from odontoblasts pass to the overlying 
epithelium, triggering the terminal differentiation of ameloblasts, an event termed as 
reciprocal induction [15]. The later stages of tooth development are distinguished by the 
formation of the mineralized structures: dentin, cementum and enamel. Enamel is the 
hardest tissue due to its high mineral content and is supported by dentin to compensate for 
its brittleness. Dentin is a mineralized, elastic, yellow-white, avascular tissue that forms 
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the bulk of the tooth and encloses the central pulp chamber. Cementum covers the dentin 
around the root portion of the tooth and provides support for attachment of the periodontal 
ligament fibers. 
Periodontium 
In mammals, to withstand the forces of mastication, teeth are attached to the jaw 
by tooth-supporting tissues consisting of the cementum, periodontal ligament (PDL), and 
alveolar bone. The periodontium develops following continuing epithelial-mesenchymal 
interactions between the oral ectoderm and the mesenchymal cells of neural crest origin 
[6]. The outermost mesenchymal layer of the tooth germ, the dental follicle, gives rise to 
periodontal structures: cementum, PDL, and alveolar bone [16]. Well-coordinated 
signaling interactions regulate proper development of the tooth periodontium complex 
[17]. Root development is initiated by the formation of Hertwig’s epithelial root sheath 
(HERS), a dual membrane of epithelial cells that extends from the cervical loop of the 
tooth germ [18]. The HERS and dental follicle cells interactions result in the development 
of periodontium cementoblasts, osteoblasts, and fibroblasts [19, 20]. Fibroblasts give rise 
to periodontal ligament fibers which anchor into cementum and in alveolar bone [21]. 
Thus, the mesenchymal cells of the dental follicle give rise to different structures of the 
periodontium. Synchronization of distinctive differentiation events is crucial for the 
proper development of the periodontium.  
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Composition of mineralized tissues 
In tooth, type I collagen is the major organic constituent of dentin and cementum, 
whereas enamel lacks collagen altogether [22]. Inorganic portion of bone and dentin 
matrices are abundant in hydroxyapatite (HA). HA is also the major constituent of enamel. 
HA crystals are deposited along the long axes of collagen fibril in the ECM of dentin, bone 
and cementum. Collagenous and non-collagenous proteins play an important role in 
regulating the growth and proliferation of these crystals. Many NCPs are phosphorylated, 
suggesting a role in mineralization process [23-31]. Type III, IV, V and VI collagens have 
been detected immunohistochemically in odontoblasts [32], but are negligible in dentin 
matrix [33]. 
Noncollagenous proteins (NCPs) 
The dentin layer produced by odontoblasts has many similarities to bone produced 
by osteoblasts [34]. Dentin is mainly composed of Collagen type I, occupying 90% of the 
organic volume whereas NCPs make up the remaining 10%. In the course of conversion 
of predentin, osteoid, and cementoid into dentin, bone, and cementum, NCPs are believed 
to play a vital role in controlling the mineralization of collagen fibers and crystal growth. 
One group of NCPs is the Small Integrin-Binding Ligand N-linked Glycoproteins 
(SIBLING) family [35]. The SIBLING family consists of five extracellular matrix 
proteins: dentin sialophosphoprotein (DSPP), dentin matrix protein 1 (DMP-1), bone 
sialoprotein (BSP), matrix extracellular glycophosphoprotein (MEPE), and osteopontin 
(OPN). SIBLING family gene cluster is located on human chromosome 4 (mouse 
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chromosome 5) (4q21). The SIBLING family proteins share several common features 
[36]. These include multiple phosphorylation sites, a highly acidic nature, the presence of 
an arginine–glycine–aspartic acid (RGD) integrin binding site, and a proteolytic resistant 
acidic serine–aspartate-rich MEPE-associated (ASARM) motif [31, 35]. SIBLING 
proteins are secreted into ECM and are believed to play critical roles in the formation of 
mineralized tissues [27, 37].  
Dentin Sialophosphoprotein 
Dentin sialophosphoprotein (DSPP; OMIM*125485) is linked to inherited dentin 
defects, dentin dysplasia (DD) type II and dentinogenesis imperfecta (DGI) type II and 
type III [38-46]. DSPP was first cloned from a mouse odontoblast cDNA library and 
consists of 5 exons and 4 introns (Fig. 1-1). The first exon is non-coding. [47]. The DSPP 
gene was primarily thought to be expressed in odontoblasts only, but recently its 
expression has been reported in osteoblasts, salivary glands, sweat glands, lungs, kidneys, 
and nasal cartilage [48-56]. Animal studies revealed that Dspp knock-out (Dspp-KO) mice 
manifest hypomineralization defects in dentin. The dentin defects in the Dspp-KO mice 
closely resemble the dentin defects of human DGI type III, with widened predentin and 
irregular dentin mineralization [57]. These findings indicate that DSPP is critical for the 
formation and mineralization of dentin. 
DSPP is proteolytically processed into the NH2-terminal and the COOH-terminal 
fragments [47, 58-60]. The 5′ portion of the DSPP transcript encodes NH2-terminal 
fragment of DSPP which exists in two forms: the core protein form known as “dentin 
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sialoprotein” (DSP) and the proteoglycan form referred to as “DSP-PG” [61-64]. The 3′ 
region of the DSPP transcript encodes the COOH-terminal fragment of DSPP which is 
referred to as “dentin phosphoprotein” (DPP). The N-terminal core protein form (DSP) 
accounts for 5–8% of the NCPs in the ECM of rat dentin [30], whereas the proteoglycan 
form (DSP-PG) appears to be more abundant than DSP [61, 65]. An in vitro study showed 
that matrix metalloproteinases (MMP-2 and MMP-20) cleaved the NH2-terminal portion 
of porcine DSPP at multiple sites, yielding several low molecular weight fragments [66]. 
The function of DSP is unclear since it has no significant effect on the formation and 
growth of HA crystals [67]. In vivo studies involving the expression of a transgene 
encoding the NH2-terminal fragment of DSPP into the Dspp-KO background indicate that 
this fragment might regulate the initiation of dentin mineralization but not the maturation 
of mineralized dentin [68].  
DPP, accounts for as much as 50% of the NCPs in the ECM of rat dentin [69]. It 
contains large amounts of aspartic acid (Asp) and serine (Ser) residues, with the majority 
of Ser being phosphorylated (Pse) [24, 70]. The high levels of Asp and Pse make DPP a 
highly phosphorylated and very acidic protein with the isoelectric point estimated to be 
1.1 for rat DPP [71]. DPP is reported to have a high affinity to calcium [26, 28] and is 
believed to have a direct role in controlling the rate and/or site of dentin mineralization 
[23, 25, 72]. DPP is an important initiator and modulator in the formation and growth of 
HA crystals [27, 73, 74].  
Although derived from the same mRNA, the remarkable chemical differences 
between DSP and DPP suggest that these molecular variants may perform different 
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functions in biomineralization. While significant amounts of DSP, DSP-PG, and DPP are 
present in the ECM of dentin, the full-length form of DSPP is found in a very minute 
quantity [75]. The abundance of DSPP fragments, but the lack of full-length DSPP in the 
dentin, suggests that the individual fragments of DSPP may be the functional forms 
responsible for its role in mineralization. 
Previous in vitro studies have shown that bone morphogenetic protein 1 
(BMP1)/Tolloid-like metalloproteinases cleave mouse DSPP at the NH2 terminus of 
Aspartic acid at position 452 (Asp452).  Substitutions of Asp452 or two residues that are 
immediately NH2-terminal to Asp452, block the processing of this protein partially or 
completely [75-77]. The astacin proteases have also been reported to cleave DSPP to 
generate DPP [78]. Transgenic mice expressing a mutant DSPP in which Asp452 was 
replaced by Alanine (Ala) has been generated; the transgene expressing this mutant DSPP 
(referred to as “D452A-DSPP”) was driven by the 3.6-kb rat Col1a1 promoter (Fig. 1-2), 
which allows the expression of this transgene in the bone and dentin. The majority of 
D452A-DSPP was not cleaved in the bone of the transgenic mice in the wild type 
background, indicating that the D452A substitution effectively blocked the proteolytic 
processing of DSPP in the mouse bone [77].  
Mineralized tissue disorders associated with DSPP 
The changes that may occur in a mineralized tissue in acquired or experimentally 
induced diseases, inheritable disorders, or in genetically modified animals, can extend our 
understanding of the role each matrix component plays in the mineralization process. This 
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is reflected in the studies of congenital diseases which occur mostly due to the absence or 
mutation of one or more genes.  
Nonsyndromic inherited dentin defects have an incidence of one in every 6000 to 
8000 individuals [79, 80]. The defects are divided into two groups: dentinogenesis 
imperfecta (DGI) and dentin dysplasia (DD) [81, 82]. Dentinogenesis imperfecta has an 
estimated incidence between 1/6000 and 1/8000, and dentin dysplasia 1/100000 [83]. 
Dentinogenesis imperfecta is classified into three types: one associated with a syndrome 
osteogenesis imperfecta (DGI type I) and two nonsyndromic (DGI type II and III);  also 
two types of dentin dysplasia (DD type I and II) have been described [38]. Dentinogenesis 
imperfecta is an autosomal dominant inherited dental disease and is characterized by 
abnormal dentin production and calcification. DGI type I is seen in patients affected by 
osteogenesis imperfecta. 
Osteogenesis imperfecta is characterized by brittle bones and frequent fractures 
[84] and is caused by mutations in the genes that code for collagen (COL1A1 and
COL1A2). 
Periodontitis is an inflammatory disease affecting the periodontium. It is caused 
by bacterial infection, mainly Aggregatibacter actinomycetemcomitans or 
Porphyromonas gingivalis. The main signs of periodontitis are  inflammation of gums, 
loss of epithelial attachment, periodontal pocket formation and excessive alveolar bone 
resorption, followed by tooth loss [85]. Moreover, several forms of inherited periodontitis 
are known (aggressive periodontitis/ juvenile periodontitis) [86, 87]. So far, however, 
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DSPP mutations have not been linked to periodontitis and most of the investigation is 
typically focused on dentin defects.  
Dentin Sialophosphoprotein and Dentin Matrix Protein 1 
Dentin matrix protein 1 (DMP1) was initially identified in odontoblasts during 
embryonic and postnatal development. DMP1 is highly expressed by osteocytes, 
chondrocytes, and preosteoblasts, unlike DSPP, which is predominantly expressed in 
odontoblasts [88]. When transgenic DMP1 was expressed using the Col1a1 promoter on 
the Dmp1 null background, it completely rescued the defects in mineralization, dentinal 
tubules, and third molar development seen in Dmp1 null mice. These defects were not 
completely rescued in molars when DMP1 was reintroduced using the DSPP promoter on 
the Dmp1 null background [89]. The lack of DMP1 in bone results in decreased 
mineralization and increased crystal size, suggesting that DMP1 is involved in bone 
formation and acts as a nucleator of mineralization [90-92]. Transgenic mice 
overexpressing either full-length DMP1 or a 57-kDa (C-terminal) fragment using the 
Col1a1 promoter were generated to test the in vivo roles of the C-terminal fragment. Both 
of the transgenic mice rescued the bone phenotypes of Dmp1 null mice, suggesting that 
the 57-kDa C-terminal fragment is able to reiterate the function of intact DMP1 in vivo 
[93]. DMP1 is also reported to regulate Dspp gene expression by binding to the Dspp 
promoter directly [94, 95]. Therefore, it is likely that the tooth phenotype of Dmp1 null 
mice is at least partially caused by diminished expression of Dspp. 
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DSPP is believed to have descended from DMP1 by a gene duplication event and 
share many similarities in both their gene and protein structures [96]. The creation of 
DSPP by DMP1 duplication event may be crucial to toothed animals to form special 
mineralized structures [97]. DSPP and DMP1 are both cleaved into two protein chains; 
the N-terminal regions are glycoslated that contain chondroitin sulfate chains, and the C-
terminal regions are highly phosphorylated [63-65, 70, 98, 99]. DSPP and DMP1 both 
play vital roles in mineralized tissue development. The in vivo roles for hard tissue 
development and mineralization have been characterized by employing many knockout 
and transgenic mouse models [57, 90, 94, 100, 101].  
Conclusion 
Role of DSPP in the formation of dentin has been studied extensively, but its role 
in other hard tissues of the periodontium like alveolar bone and cementum is not yet 
studied. The expression level of DSPP in bone is much less than in dentin, however, its 
role in long bone is not known [48]. DSPP has been shown to play an essential role in 
periodontal tissues. Dspp deficient mice manifest severe alveolar bone loss with reduced 
cementum deposition and altered osteocyte morphology [102]. In vivo studies showed that 
proteolytic processing into fragments is vital for DSPP function in dentinogenesis [103]. 
It is still unclear whether the proteolytic processing of DSPP is also essential for its 
biological function in maintaining periodontal health. To evaluate this, transgenic mice 
expressing the uncleavable full-length DSPP in the Dspp-KO background were analyzed. 
In the first aim of this study, we characterized the alveolar bone and cementum of the mice 
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expressing the mutant DSPP transgene in comparison with wild-type (WT) mice, Dspp-
KO mice, and mice expressing the normal DSPP transgene in the Dspp-KO background. 
DPP is a strong initiator and regulator for the formation and growth of HA crystals 
[73, 74], while DSP has no significant effects on these crystals [67]. Overexpressing the 
NH2-terminal fragment of DSPP (including both DSP and DSP-PG) worsened the dentin 
defects in Dspp-KO mice[104], indicating that DSP and/or DSP-PG may inhibit the 
formation and mineralization of dentin. The second aim of this investigation focuses on 
the specific roles of the NH2-terminal fragments of DSPP in periodontium, by analyzing 
the alveolar bone, cementum and periodontal ligaments in the mutant mice overexpressing 
the NH2-terminal fragment of DSPP but lacking the endogenous Dspp gene. 
The role of DMP1 in osteogenesis has been studied at length, but function of DSPP 
in long bones has been studied only to a limited extent. Transgenic expression of DSPP 
was able to completely reverse the dentin and alveolar bone defects of Dmp1-null mice 
[105]. In the third aim of this investigation, we assessed the effects of transgenic DSPP on 
bone formation by analyzing the development and mineralization of the long bones in 
Dmp1-null mice that expresses a transgene encoding full-length DSPP driven by a 3.6-kb 
rat Col1a1 promoter. Together, these studies shed new light on the significant function of 
DSPP in mineralized tissue formation 
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CHAPTER II 
FAILURE TO PROCESS DENTIN SIALOPHOSPHOPROTEIN (DSPP) INTO 
FRAGMENTS LEADS TO PERIODONTAL DEFECTS IN MICE 
Synopsis 
Dentin sialophosphoprotein (DSPP) is known to play a vital role in dentinogenesis. 
DSPP in dentin is processed into the NH2-terminal and COOH-terminal fragments. This 
proteolytic processing is essential to normal dentinogenesis. Besides its role in tooth 
formation, recent studies from our laboratory showed that in addition to dentin, DSPP is 
also highly expressed in the alveolar bone and cementum and that DSPP plays an essential 
role in maintaining periodontal integrity. In Dspp deficient mice, severe periodontal 
defects were observed, which included alveolar bone loss, decreased cementum 
deposition, abnormal osteocyte morphology in the alveolar bone, as well as the apical 
migration of periodontal ligament. It is still unclear whether the proteolytic processing of 
DSPP is also essential for its biological function in maintaining periodontal health. To 
evaluate this, we analyzed transgenic mice expressing the uncleavable full-length DSPP 
in the Dspp knockout (Dspp-KO) background (referred to as “Dspp-KO/D452A-Tg”  
*Reprinted with permission from “Failure to process dentin sialophosphoprotein into
fragments leads to periodontal defects in mice” by MP Gibson, P Jani, Y Liu, X Wang, Y 
Lu, JQ Feng, C Qin, 2013. European Journal of Oral Science 2013; 121: 545–550, 
Copyright 2013 by European Journal of Oral Science. 
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mice). We characterized the alveolar bone and cementum of the Dspp-KO/D452A-Tg 
mice; in comparison with wild-type (WT) mice, Dspp-KO mice, and mice expressing the 
normal DSPP transgene in the Dspp-KO background (referred to as Dspp-KO/normal-Tg 
mice). Results from this study showed that the expression of the normal DSPP was able 
to rescue the periodontal defects of the Dspp-KO mice, whereas expressing Dspp-
KO/D452A-Tg failed to do so. These results indicate that the proteolytic processing of 
DSPP is crucial for periodontal integrity.  
Introduction 
Dentin sialophosphoprotein (DSPP), first discovered by cDNA cloning in 1997, 
plays a crucial role in dentinogenesis [39]. It undergoes post-translational modification 
and is cleaved into the NH2-terminal fragments [existing in two forms: dentin sialoprotein 
(DSP) and the proteoglycan form termed DSP-PG] and COOH-terminal fragment [dentin 
phosphoprotein (DPP) [47, 58, 59]. Genetic studies have shown the association of DSPP 
mutations with dentinogenesis imperfecta (DGI) in humans [41-44, 106-108]. In animal 
models, Dspp-knock out (Dspp-KO) exhibits severe dentin hypomineralization defects 
with widened predentin zone resembling the dentin defects observed in human DGI [57]. 
These findings strongly suggest the importance of DSPP in the formation and 
mineralization of dentin. 
          Besides its established role in tooth formation, DSPP was also discovered in bone, 
cementum and several non-mineralized tissues [48, 50-52, 54, 109-112]. Its expression in 
alveolar bone and cementum is remarkably higher than in the long bone [110, 112].  
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Recent work from our laboratory showed that DSPP plays an essential role in these 
periodontal tissues [113]. In Dspp deficient mice we observed severe alveolar bone loss 
with reduced cementum deposition and altered osteocyte morphology [113]. The 
reduction in interdental alveolar bone caused apical migration of periodontal ligaments 
(PDL) leading to periodontal pockets [113]. In vivo studies done by our group showed that 
proteolytic processing of DSPP is vital for its function in dentinogenesis [103]. However, 
whether the same mechanism applies in periodontal tissues still remains to be tested. For 
this purpose, we systematically characterized the alveolar bone and cementum of the 
following groups of mice: 1) mice expressing the uncleavable D452A-DSPP in the Dspp-
KO background (named as Dspp-KO/D452A-Tg mice); 2) Dspp-KO mice; 3) Wild-type 
(WT) mice and; 4) mice expressing the normal DSPP transgene in the Dspp–KO 
background (referred as Dspp-KO/normal-Tg mice). The results from this study showed 
that expression of normal DSPP was successful in rescuing the periodontal defects of 
Dspp-KO mice. However the transgenic expression of D452A-DSPP was unable to rescue 
the Dspp deficient defects. The findings from from this study provide in vivo evidence that 
the proteolytic processing of DSPP is necessary for maintaining the health of periodontal 
tissues.  
Materials and methods 
Mouse generation  
Detailed description for the generation of transgenic mice used in this study has 
been described in our recent reports [103, 114]. Briefly, the D452A-DSPP and the normal 
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DSPP constructs are downstream to the 3.6-kb rat Col 1a1 promoter. The mouse lines that 
were crossbred with Dspp-KO mice (strain name: B6; 129-Dspptm1Kul/Mmnc; 
MMRRC, UNC, Chapel Hill, NC) and characterized in our recent study by Zhu et al. [114] 
were used in this investigation. The mice expressing the D452A-DSPP transgene in the 
Dspp-KO background are referred to as Dspp-KO/D452A-Tg mice while those expressing 
the normal DSPP transgene in the Dspp-KO background are called Dspp-KO/normal-Tg 
mice. Primers used for genotyping the transgenic and Dspp knockout mice have been 
described previously [114]. The animal protocols used in this study were approved by the 
Animal Welfare Committee of Texas A&M Univerisity Baylor College of Dentistry 
(Dallas, TX).  In this study we analyzed the alveolar bone and cementum of the following 
four groups of mice: Dspp-KO/D452A-Tg mice, WT (C57/BL6J) mice, Dspp-KO mice 
and Dspp-KO/normal-Tg mice.  
Histology 
Under anesthesia, 3- and 6-months-old Dspp-KO/ D452A-Tg, WT, Dspp-KO and 
Dspp- KO/normal-Tg mice were perfused from the ascending aorta with 4% 
paraformaldehyde in 0.1 M phosphate buffer. The dissected mandibles were then fixed in 
the same fixative for 24 h, and then decalcified for approximately 2 weeks using the 
protocols as we previously described [114]. The tissues were then embedded in paraffin, 
and serial sections of 5 μm were prepared and stained with hematoxylin & eosin (H&E).  
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Micro-computed tomography (μ-CT) 
Samples from the above mentioned four groups of mice at 3- and 6-months of age 
were analyzed by micro-computed tomography (μ-CT) using a μ-CT35 imaging system 
(Scanco Medical, Bassersdorf, Switzerland). A high-resolution scan (3.5 μm slice 
increment) of the alveolar bone in the furcation of the first mandibular molar with a fixed 
dimension for all samples was performed. The data acquired from five samples per group 
were used for quantitative analyses using the Student's t-test. p < 0.05 was considered 
statistically significant, and the data are presented as mean ± SD. 
Backscattered and resin-casted Scanning Electron Microscopy (SEM) 
The mandibles from the four groups of mice at 3-months of age were dissected and 
prepared as we previously described [113]. For backscattered scanning electron 
microscopy (SEM), the specimens were coated with carbon and examined with a 
FEI/Philips XL30 Field emission environmental SEM (Philips, Hillsboro, OR, USA). 
Following this, the surface was acid etched [113], coated with gold and palladium, and 
examined with SEM.  
Results 
Failure to process DSPP into fragments leads to alveolar bone defects 
Results from the histological analyses showed severe alveolar bone loss with 
marked increase in inflammatory cells in the furcation region of the first mandibular molar 
in Dspp-KO mice at 3- and 6-months of ages (Figs. 2-1 D and H), when compared to the 
WT samples of the same ages (Figs. 2-1 A and E).  The transgenic expression of D452A-
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DSPP was unable to rescue these alveolar bone defects (Figs. 2-1 B and F) and resembled 
those of the Dspp-KO mice (Figs. 2-1 D and H). However, the alveolar bone of Dspp-KO/ 
normal-Tg mice at both ages (Figs. 2-1 C and G) appeared similar to the WT samples 
(Figs. 2-1 A and E) and hence, the transgenic expression of the normal DSPP was able to 
reverse the Dspp deficient alveolar bone defects to normal. 
          Results from the μ-CT analyses (Figs. 2-2 A and B) also showed that the transgenic 
expression of normal DSPP was able to revert the bone volume fraction of Dspp-KO mice 
to a level comparable to the WT mice at both 3-months (Fig. 2-2 A) and 6-months (Fig. 
2-2 B) of age, whereas, the expression of D452A-DSPP was unable to achieve the same
result. 
Failure to process DSPP into fragments leads to loss of epithelium attachment in the 
interdental region  
In the interdental regions between the first and second mandibular molars, the WT 
(Figs. 2-3 A and E) and Dspp-KO/ normal-Tg mice (Figs. 2-3 C and G) showed epithelial 
attachment at the cemento-enamel junction (CEJ) with healthy interdental alveolar bone 
deposition at both 3- and 6-months of age. However, in the Dspp-KO (Figs. 2-3 D and H) 
and Dspp-KO/ D452A-Tg mice (Figs. 2-3 B and F), the H&E staining showed a 
remarkable loss of alveolar bone and disruption of periodontal ligaments interdentally, 
along with the apical migration of the junctional epithelium. The defects in the Dspp-KO 
(Fig. 2-3 H) and Dspp-KO/ D452A-Tg mice (Fig. 2-3 F) appeared worse at 6-months of 
age with the epithelial attachment recessing even more apically than at the age of 3 
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months. 
Failure to process DSPP into fragments leads to decreased cementum deposition 
Using backscattered and resin-casted SEM (Fig. 2-4), we observed an overall loss 
of cementum in the apical region of mandibular first molar in the 3-month-old Dspp-KO 
(Figs. 2-4 D and H) and Dspp-KO/ D452A-Tg mice (Figs. 2-4 B and F), when compared 
with the WT mice of the same ages (Figs. 2-4 A and E). The transgenic expression of 
normal DSPP in the Dspp-KO/ normal-Tg mice (Figs. 2-4 C and G) was able to rescue the 
loss of cementum to a great extent. The cementum deposition in the Dspp-KO/ normal-Tg 
mice (Figs. 2-4 C and G) still showed some differences from the WT sample (Figs. 2-4 A 
and E), but was markedly improved when compared with the Dspp-KO (Fig. 2-4 D and 
H) and Dspp-KO/ D452A-Tg mice (Fig. 2-4 B and F).
Discussion 
Previous in vivo experiments showed that the proteolytically processed NH2-
terminal and COOH-terminal fragments (including DSP, DSP-PG, and DPP) of DSPP are 
the active forms essential for dentinogenesis [114].  In the present study, we analyzed the 
periodontium of the same mouse lines used in our previous study [114] to examine 
whether transgenic expression of D452A-DSPP (in which Asp452, a key cleavage-site 
residue, was replaced by Ala452) or normal-DSPP could rescue the phenotypes observed 
in alveolar bone and cementum of Dspp deficient mice.  We found that transgenic 
expression of normal-DSPP (with no mutation at the cleavage site) was able to rescue the 
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alveolar and cementum phenotypes in Dspp-deficient mice to a level comparable to the 
WT mice, but the D452A-DSPP transgene failed to do so. These results support that 
similar to dentinogenesis, the proteolytic processing of DSPP is an activation step, 
essential for the development and maintenance of the periodontium.   
          Accumulating evidence suggest that the periodontal defects observed in Dspp 
deficient mice are due to the intrinsic defects in alveolar bone and cementum caused by 
loss of DSPP function, but are not secondary to the chronic periodontitis. First, Dspp is 
highly expressed in the alveolar bone and cementum [110, 113]; Second, our current study 
showed that transgenic expression of normal Dspp rescued the periodontal defects of Dspp 
deficient mice; Third, detailed analyses showed that the alveolar bone loss occurred 
independently from and even earlier than chronic periodontitis in these Dspp deficient 
mice (data not shown). However, inflammation may exacerbate the periodontal defects in 
Dspp deficient mice as chronic periodontitis itself also could cause alveolar bone loss and 
periodontal ligament destruction. Therefore, it remains to be determined whether 
treatment or prevention of the chronic periodontitis would relieve or rescue the periodontal 
defects seen in Dspp deficient mice.  
The present study suggests that the function of DSPP may be mediated by its 
processed fragments. However, the proteolytic processing of DSPP gives rise to three 
fragments: DSP, DSP-PG and DPP, each of these may have a specific role in the 
periodontal tissues. Therefore, it is essential to find out the roles of each of these fragments 
in the alveolar bone and cementum.  We recently found that the NH2-terminal fragment 
of DSPP (DSP and DSP-PG) have an inhibitory effect on dentinogenesis [104]. 
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Presumably, DSP and DSP-PG may have similar inhibitory roles in the alveolar bone and 
cementum. Considering the tooth and periodontal defects of Dspp deficient mice, it would 
be reasonable to point out that the DPP fragment may carry the stimulatory effects on 
dentinogenesis and periodontal development. In the future, it would be necessary to dissect 
out that the inhibitory effects are mediated by DSP or DSP-PG or both of them, and to 
determine whether the stimulatory effects are mediated by the DPP. 
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CHAPTER III 
OVEREXPRESSING THE NH 2-TERMINAL FRAGMENT OF DENTIN 
SIALOPHOSPHOPROTEIN (DSPP) AGGRAVATES THE PERIODONTAL 
DEFECTS IN DSPP KNOCKOUT MICE 
Synopsis 
Previous studies have shown that dentin sialophosphoprotein (DSPP) is not only 
essential to the formation and mineralization of dentin but also plays an important role in 
forming and maintaining a healthy periodontium. Under physiological conditions, DSPP 
is proteolytically processed into the NH2-terminal and COOH-terminal fragments, and 
these fragments are believed to perform different functions in the mineralized tissues. 
Previous studies in our group have demonstrated that the NH2-terminal fragment of 
DSPP inhibits the formation and mineralization of dentin, while the role of this fragment 
in periodontium is unclear.  We analyzed the periodontal tissues of the transgenic mice 
overexpressing the NH2-terminal fragment of DSPP in the Dspp knockout background 
(referred to as “Dspp KO/DSP Tg” mice), in comparison with wild type mice and Dspp  
*Reprinted with permission from “Overexpressing the NH2-terminal fragment of dentin
sialophosphoprotein (DSPP) aggravates the periodontal defects in Dspp knockout mice” 
by MP Gibson, P Jani, X Wang, Y Lu, C Qin, 2014. Journal of Oral Biosciences, Volume 
56, Issue 4, November 2014, Pages 143-148, Copyright 2014 by Journal of Oral 
Biosciences. 
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knockout mice. Dspp KO/DSP Tg mice exhibited a greater reduction of the alveolar bone, 
more remarkably altered canalicular systems around the osteocytes, less cementum, more 
radical migration of the epithelial attachment towards the apical direction, and more severe 
inflammation in molar furcation region, than in the Dspp knockout mice. Thus, 
overexpressing the NH2-terminal fragment of DSPP worsened the periodontal defects in 
Dspp knockout mice, indicating that the NH2-terminal fragment of DSPP may exert an 
inhibitory role in the formation and mineralization of hard tissues in the periodontium. 
Introduction 
Dentin sialophosphoprotein (DSPP) discovered by cDNA cloning using an 
odontoblast library was intitailly thought to be dentin-specific [37, 47]. Later on, its 
expression was also found in the long bone, alveolar bone and cementum [48, 115]. 
Genetic studies have shown an association of DSPP mutations with dentinogenesis 
imperfecta (DGI) in humans [41-44]. Gene ablation studies revealed that Dspp knockout 
(Dspp KO) mice have severe dental defects characterized by dentin hypomineralization, 
widened predentin zone and enlarged pulp chamber, resembling the tooth defects observed 
in human DGI [57]. These in vivo studies have confirmed the critical role of DSPP in 
dentinogenesis. A recent study by our group has shown that Dspp KO mice develop 
periodontal diseases manifesting a reduction of alveolar bone, decreased deposition of 
cementum and altered morphology of osteocytes in the alveolar bone [102].  These recent 
findings indicate that in addition to its critical role in dentin formation, DSPP is also 
essential for the formation and maintenance of a healthy periodontium. 
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Physiologically, DSPP is proteolytically cleaved by astacin proteases into the 
NH2-terminal and COOH-terminal fragments [47, 58, 59, 78]. The NH2-terminal 
fragments of DSPP exist in the extracellular matrix (ECM) of rat/mouse dentin as two 
forms, dentin sialoprotein (DSP) and the proteoglycan form of this fragment (DSP-PG); 
the former has no glycosaminoglycan (GAG) chains while the latter has two GAG chains 
made of chondroitin-4-sulfate [64, 112]. The COOH-terminal fragment of DSPP is 
referred to as dentin phosphoprotein (DPP) [64]. Previous studies in our group have 
established that the posttranslational processing (cleavage) of mouse DSPP at the NH2-
terminus of Asp452 is an activation step essential to the formation and mineralization of 
dentin and alveolar bone [114, 116].  We have shown that the substitution of Asp452 by 
Ala452 prevents the cleavage of DSPP into fragments, which subsequently leads to defects 
in the mouse dentin and periodontium [114, 116].  
The exact mechanisms of how the cleaved fragments of DSPP function in the 
dentin and periodontal tissues remain largely unknown.  In vitro analyses have shown that 
DPP is a strong initiator and regulator for the formation and growth of hydroxyapatite 
crystals [73, 74], while DSP (the NH2-terminal fragment of DSPP without the GAG 
chains) has no significant effects on the formation and growth of hydroxyapatite crystals 
[67]. Recent in vivo studies have demonstrated that overexpressing the NH2-terminal 
fragment of DSPP (including both DSP and DSP-PG) worsened the dentin defects in Dspp 
KO mice [104], indicating that DSP and/or DSP-PG may inhibit the formation and 
mineralization of dentin. This investigation focuses on the specific roles of the NH2-
terminal fragments of DSPP in periodontium, by analyzing the alveolar bone, cementum 
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and periodontal ligaments in the mutant mice overexpressing the NH2-terminal fragment 
of DSPP but lacking the endogenous Dspp gene. Our results showed that overexpressing 
the NH2-terminal fragment of DSPP worsened the periodontal defects in Dspp KO mice.  
Materials and methods 
Generation of transgenic mice overexpressing the NH2-terminal fragment of DSPP in 
the Dspp-knockout background (Dspp KO/DSP Tg mice) 
Detailed procedures for the generation of transgenic mice overexpressing the NH2-
terminal fragment of DSPP driven by a type I collagen promoter have been described in 
our previous publication [104]; these transgenic mice are named “DSP Tg mice”.  We 
crossbred DSP Tg mice with Dspp KO mice obtained from the Mutant Mouse Regional 
Resource Center (MMRRC, UNC, Chapel Hill, NC), to generate a line of mutant mice 
that express the transgene encoding the NH2-terminal fragment of DSPP but lack the 
endogenous Dspp; this line of mutant mice is referred to as “Dspp KO/DSP Tg” mice. 
Detailed information regarding the genotyping primers and the expression level of the 
transgene can be found in our precious report [104]. We employed histology, micro-
computed tomography and scanning electron microscopy to assess the periodontal tissues 
of Dspp KO/DSP Tg mice, in comparison with those of the wild type (WT) and Dspp KO 
mice.  
Histology (H&E staining) 
For histology analyses, 3-month-old Dspp KO/DSP Tg, WT and Dspp KO mice 
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were perfused from the ascending aorta with 4% paraformaldehyde (Sigma Aldrich 
Corporation, St. Louis, MO) in 0.1 M phosphate buffer. The heads form the sacrificed 
animals were then fixed in 4% paraformaldehyde for 48 hours and then decalcified in 8% 
EDTA (pH 7.4) (Sigma Aldrich Corporation, St. Louis, MO) at 4°C for approximately 2 
weeks. The dissected mandibles were embedded in paraffin, and serial sections of 5 μm 
were prepared from these paraffin blocks. The sections were stained with hematoxylin & 
eosin (H&E) and observed under an Olympus microscope (Olympus BX51, Olympus 
Corporation, Center Valley, PA USA).  
Micro-computed tomography (μ-CT) 
We dissected the mandibles from the 3-month-old and 6-month-old WT, Dspp KO, 
and Dspp KO/DSP Tg mice (3 mice for each age group; i.e., totally, 6 animals for each 
type of mice). The mandibles were analyzed using the μ-CT (μ-CT 35 imaging system, 
Scanco Medical, Basserdorf, Switzerland), as we previously described [114, 117]. We 
performed high-resolution scans (3.5 µm/slice) and three-dimensional reconstructions to 
assess the morphological characteristics of the mouse mandibles and to calculate the ratios 
of alveolar bone volume to total volume (BV/TV), among the three groups of mice at both 
ages.  The BV/TV values were expressed as mean ±SD. Student’s t-test was adopted in 
our statistical analyses to determine the significance levels of differences between two 
individual groups, using SPSS (SPSS v.17.0, IBM, Somers, NY). 
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Back scattered and resin-casted scanning electron microscopy (SEM) 
For these experiments, the mandibles from 3-month-old mice (n = 3 for each type 
of mice) were dissected and fixed in 2% paraformaldehyde with 2.5% glutaraldehyde 
(Sigma Aldrich Corporation, St. Louis, MO) in 0.1 M cacodylate buffer solution (pH 7.4) 
at room temperature. The detailed protocols used for processing, polishing and coating 
samples for back scattered and resin-casted SEM (Philips XL30 FEI scanning electron 
microscope, Philips, Hillsboro, OR, USA) analyses have been described in previous 
studies [102, 114]. 
Results 
Inflammatory infiltration and migration of epithelial attachment in the periodontium 
of Dspp KO/DSP Tg mice  
Results from H&E staining demonstrated that when compared to the WT controls 
(Fig. 3-1 A), the furcation region of the mandibular molar in Dspp KO mice (Fig. 3-1 B) 
and Dspp KO/DSP Tg mice (Fig. 3-1 C) had obvious inflammatory infiltration. The 
inflammatory reaction appeared more prevalent and severe in the Dspp KO/DSP Tg (Fig. 
3-1 C) than in the Dspp KO mice (Fig. 3-1 B).
In comparison with the WT mice (Fig. 3-2 A), both types of the mutant mice (Fig. 
3-2 B, 3-2 C) showed the detachment and migration of the junctional epithelium, along
with the disruption of periodontal ligaments in the interdental region between the 
mandibular first and second molars. The above defects in the Dspp KO/DSP Tg mice (Fig. 
3-2 C) were much more severe than in the Dspp KO mice (Fig. 3-2 B).
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Reduction of alveolar bone in Dspp KO/DSP Tg mice 
Results from both H&E staining (Figs. 3-1, 3-2) and μ-CT analyses (Fig. 3-3) 
showed that the reduction of alveolar bone in the Dspp KO/DSP Tg mice was greater than 
in Dspp KO mice. In the H&E-stained sections, Dspp KO mice (Fig. 3-1 B) showed a 
moderate loss of alveolar bone in the furcation region of the first mandibular molar when 
compared to the WT control (Fig. 3-1 A), while the same region in the Dspp KO/DSP Tg 
mice (Fig. 3-1 C) was completely engulfed with the inflammatory cells and had only a 
few islands of bone left with the majority of the alveolar bone structures being destroyed. 
When the alveolar bone volume fractions (BV/TV) were compared among the 
three types of mice (Fig. 3-3 A and B), the Dspp KO/DSP Tg mice had the least values of 
BV/TV in either the 3- or 6-month-old age groups. The differences in BV/TV values were 
statistically significant between the Dspp KO and Dspp KO/DSP Tg mice at both ages.  
Loss of cellular cementum in Dspp KO/DSP Tg mice 
Using backscattered and resin-casted SEM approaches (Fig. 3-4), we observed an 
overall reduction of cellular cementum in the mandibular first molars of the Dspp KO 
(Figs. 3-4 B and 3-4 E) and Dspp KO/DSP Tg mice (Figs. 3-4 C and 3-4 F). The periapical 
region of the mandibular first molars in the Dspp KO/DSP Tg mice (Figs. 3-4 C and 3-4 
F) had the least amounts of cementum when compared to the WT control (Figs. 3-4 A and
3-4 D) or the Dspp KO mice (Figs. 3-4 B and 3-4 E).
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Alteration of the osteocyte lacunae and canalicular system in the alveolar bone of Dspp 
KO/DSP Tg mice 
The osteocyte lacunae in the alveolar bone of WT mice were well organized and 
evenly spaced with most of the canaliculi radiating in directions perpendicular to the long 
axis of the osteocyte bodies (Fig. 3-5 A).  In contrast, the osteocyte lacunae in the alveolar 
bone of the Dspp KO mice appeared irregular with disorganized and fewer canaliculi (Fig. 
3-5 B). The osteocyte lacunae in the alveolar bone of Dspp KO/DSP Tg mice were 
extremely disorganized and had very few osteocyte canaliculi (Fig. 3-5 C).  The osteocyte 
canaliculi in the alveolar bone of the Dspp KO/DSP Tg mice (Fig. 3-5 C) also had a 
reduced extension into the surrounding bone compared to Dspp KO mice (Fig. 3-5 B).  It 
was apparent that the defects of the osteocyte lacunae and the structures surrounding the 
lacunae in the alveolar bone of Dspp KO/DSP Tg mice were worse than those of the Dspp 
KO mice. 
Discussion 
DSPP is expressed in dentin, cementum, alveolar bone, long bone and several non-
mineralized tissues [54, 64]. Previously, our group showed that the expression level of 
DSPP in the alveolar bone and cellular cementum is significantly higher than that in the 
long bone [64, 115]. In the periodontal structures, DSPP was found in the osteocytes of 
the alveolar bone, cementocytes of cellular cementum in the apical region as well as in the 
matrices surrounding these mineralized tissue-forming cells [115]. There are a number of 
reports regarding the biological roles of DSPP and the mechanistic aspects of this protein 
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in dentinogenesis [41-44, 57, 105, 114], whereas little information is available regarding 
the biological functions of this molecule in periodontium. Recent work from our group 
has shown that deletion of DSPP leads to periodontal disease in mice and has established 
the essential role of this molecule in maintaining the integrity of the periodontium [64]. 
The current study provides new knowledge about the molecular mechanisms by which 
DSPP functions in the periodontal tissues.  
DSPP is present in the ECM of dentin as three forms found at significant levels 
[64]: 1) DSP (the NH2-terminal fragment without GAG chains, containing little or no 
phosphorylation), 2) DSP-PG (the proteoglycan form of the NH2-terminal fragment, 
possessing two GAG chains), and 3) DPP (the COOH-terminal fragment, very highly 
phosphorylated).  Based on their differences in chemical property and tissue distribution 
profiles, these three molecular variants derived from the amino acid sequence of DSPP are 
believed to play different functions [64, 118]. In this study, we analyzed the specific role 
of the NH2-terminal fragment of DSPP in periodontium, using transgenic mice 
overexpressing this fragment. 
We found that overexpressing the NH2-terminal fragment of DSPP aggravated the 
periodontal defects in Dspp KO mice; the periodontal deterioration in the Dspp KO/DSP 
Tg mice evident in the multipronged analyses included more severe inflammatory 
infiltration around the alveolar bone, more significantly reduced propagation of the 
osteocyte processes into surrounding alveolar bone, greater reduction of interradicular and 
interdental bone,  greater loss of cellular cementum,  and more radical migration of 
junctional epithelium towards the apex, in comparison with the Dspp KO mice. The 
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periodontal deteriorations in Dspp KO/DSP Tg mice were likely due to more severe 
defects in the alveolar bone and cementum, which lead to secondary effects (including 
inflammation) on the periodontal ligament and to the formation of deeper periodontal 
pockets. The exacerbated abnormality in the morphology of osteocytes and canaliculi in 
the alveolar bone of Dspp KO/DSP Tg mice indicate that the defect of the alveolar bone 
must be due to intrinsic factors of bone cells associated with the overexpression of the 
NH2-terminal fragment of DSPP. 
In a previous study, Suzuki et al [68] generated transgenic mice expressing the 
NH2-terminal fragment of DSPP driven by the mouse Dspp promoter and showed that 
transgenic expression of this fragment partially rescued the tooth defects in Dspp-null 
mice. We think that the variance between our studies and the previous one may be 
attributed to the use of different promoters.  
The NH2-terminal fragments of DSPP exist as two forms: DSP and DSP-PG [64]. 
While the exact ratio of DSP to DSP-PG is unknown, it appears that DSP-PG is a major 
proteoglycan in the dentin matrix [61, 62, 64]. In vitro mineralization analyses showed 
that DSP has no significant effects on the formation and growth of hydroxyapatite 
crystals [67] while information regarding the biological roles of DSP-PG is lacking. In this 
study, overexpressing the NH2-terminal fragment of DSPP in the type I collagen-
expressing tissues (dentin, bone, cementum and periodontal ligaments) aggravated the 
periodontal defects of Dspp KO mice, indicating that the NH2-terminal fragment of this 
protein may play an inhibitory role in the formation and mineralization of hard tissues in 
the periodontium.  However, we do not know which of the two molecular species (i.e., 
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DSP or DSP-PG) derived from the NH2-terminal fragment of DSPP is responsible for the 
exacerbated phenotypic changes in the Dspp KO/DSP Tg mice.  Future studies are 
warranted to define which of the two NH2-terminal forms is exerting the inhibitory 
functions in the formation and mineralization of hard tissues in the periodontium.  
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CHAPTER IV  
TRANSGENIC EXPRESSION OF DSPP PARTIALLY RESCUED THE LONG BONE 
DEFECTS OF DMP1-NULL MICE 
Synopsis 
Dentin matrix protein 1 (DMP1) and dentin sialophosphoprotein (DSPP) belong 
to the Small Integrin-Binding Ligand N-linked Glycoprotein (SIBLING) family. In 
addition to the features common to all SIBLING members, DMP1 and DSPP share several 
unique similarities in chemical structure, proteolytic activation and tissue localization. 
Mutations in, or deletion of DMP1, cause autosomal recessive hypophosphatemic rickets 
along with dental defects; DSPP mutations or its ablation are associated with 
dentinogenesis imperfecta. While the roles and functional mechanisms of DMP1 in 
osteogenesis have been extensively studied, those of DSPP in long bones have been 
studied only to a limited extent. Previous studies by our group revealed that transgenic 
expression of Dspp completely rescued the dentin defects of Dmp1-null (Dmp1-/-) mice. 
In this investigation, we assessed the effects of transgenic Dspp on osteogenesis by 
analyzing the formation and mineralization of the long bones in Dmp1-/- mice that 
expresses a transgene encoding full-  
*Reprinted with permission from “Transgenic expression of Dspp partially rescued the
long bone defects of Dmp1-null mice” by PH Jani, MP Gibson, C Liu, H Zhang, X Wang, 
Y Lu, C Qin, 2016. Matrix Biology, Volumes 52–54, May–July 2016, Copyright 2016 by 
Matrix Biology. 
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length DSPP driven by a 3.6-kb rat Col1a1 promoter (referred as “Dmp1-/-;Dspp-Tg 
mice”). We characterized the long bones of the Dmp1-/-;Dspp-Tg mice at different ages 
and compared them with those from Dmp1-/- and normal control mice. Our analyses 
showed that the long bones of Dmp1-/-;Dspp-Tg mice had a significant increase in cortical 
bone thickness, bone volume and mineral density along with a remarkable restoration of 
trabecular thickness compared to those of  the Dmp1-/- mice. The long bones of Dmp1-
/-;Dspp-Tg mice underwent a dramatic reduction in the amount of osteoid, significant 
improvement of the collagen fibrillar network, and better organization of the 
lacunocanalicular system, compared to the Dmp1-/- mice. The elevated levels of biglycan, 
bone sialoprotein and osteopontin in Dmp1-/- mice were also noticeably corrected by the 
transgenic expression of Dspp. These findings suggest that DSPP and DMP1 may function 
synergistically within the complex milieus of bone matrices.  
Introduction 
The organic components in the extracellular matrix (ECM) of bone are composed 
of collagen type I and a number of non-collagenous proteins (NCPs). One family of NCPs 
is the Small Integrin-Binding Ligand N-linked Glycoprotein (SIBLING) family, which 
consists of osteopontin (OPN), bone sialoprotein (BSP), dentin matrix protein 1 (DMP1), 
dentin sialophosphoprotein (DSPP) and matrix extracellular phosphoglycoprotein 
(MEPE) [35]. These SIBLING family members play important biological roles in the 
formation and mineralization of bone and dentin [35, 119-121], as evidenced by the 
35 
observations that mutations in or ablation of their genes are associated with developmental 
abnormalities in the two tissues [41, 42, 90]. 
DMP1, first cloned from a rat odontoblast cDNA library, has been identified in 
dentin, bone and cementum as well as in some non-mineralized tissues [29, 122, 123]. In 
the appendicular skeleton, DMP1 is expressed by osteocytes, osteoblasts and hypertrophic 
chondrocytes [124-126]. Dmp1-deficient mice displayed severe defects in the cartilage 
and bone, which resembled the manifestations of autosomal recessive hypophosphatemic 
rickets (ARHR), a human hereditary disease caused by mutations in the DMP1 gene. This 
condition was characterized by the elevation of serum fibroblast growth factor 23 (FGF23) 
and a reduction of serum phosphorus, along with malformed and hypomineralized bone 
and dentin [91, 92].  Although DSPP was originally thought to be exclusively expressed 
by odontoblasts, the dentin-forming cells, later on its expression was detected in bone, 
cementum and certain non-mineralizing tissues including the salivary glands and kidneys 
[48, 54, 111, 127]. Our previous studies showed that the expression level of DSPP in the 
rat long bone is approximately 1/400th  of that in the rat dentin [48]. Mouse and human 
genetic studies have associated DSPP mutations or its ablation with dentinogenesis 
imperfecta, characterized by thinner dentin, enlarged pulp chamber and widened predentin 
[41, 42, 57, 108]. While Dspp knockout mice have severe defects in the formation and 
mineralization of dentin, the changes in the long bones of Dspp-deficient mice are mild 
[101].  
Certain pieces of evidence suggest a possible functional relationship between 
DMP1 and DSPP [96, 122, 127]. The dentin defects in Dmp1-/- mice  are similar to those 
36 
in Dspp-/- mice [57, 94] and the dentin of the Dmp1-/- mice has a reduced level of DSPP 
expression [94]. In vitro studies revealed that DMP1 localizes in the nucleus during the 
differentiation of odontoblasts and is bound to and activates the Dspp promoter in 
odontoblast cell lines [95]. While DMP1 has been shown to play a crucial role in 
osteogenesis [91, 100, 128] and chondrogenesis [90], Dspp ablation in mice  or its 
mutations in human dentinogenesis imperfecta subjects do not cause severe defects in the 
long bone, although Dspp-knockout mice have obvious alveolar bone abnormalities  [101, 
102]. Previously, we showed that the transgenic expression of Dspp rescued the dentin 
and alveolar bone defects of Dmp1-/- mice [105]. To further elucidate the molecular 
mechanisms by which DMP1 interacts with DSPP in osteogenesis, we systematically 
characterized the long bones of Dmp1-/- mice that express a transgene encoding full-length 
DSPP driven by a type I collagen promoter to determine whether or how much the 
transgenic expression of Dspp would rescue the long bone defects of Dmp1-deficient 
mice.  
Results 
In this study, the mice heterozygous for Dmp1  (Dmp1+/-) were used as normal 
controls for comparison, as these mice do not manifest any developmental abnormalities 
compared to wild type mice [7, 10, 14]. 
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Expression of Dspp in the long bones of normal control, Dmp1-/- and Dmp1-/-;Dspp-Tg 
mice 
In order to compare the DSPP expression in the long bones of normal control 
(Dmp1+/-), Dmp1-/- and Dmp1-/-;Dspp-Tg mice, real-time quantitative polymerase chain 
reaction (RT-qPCR), immunohistochemical (IHC) staining and in situ hybridization (ISH) 
were performed. RT-qPCR analyses (Fig. 4-1a) showed that the DSPP mRNA level in the 
long bone of Dmp1-/- mice was reduced by approximately one-third compared to the 
normal control, while the DSPP mRNA level in the long bone of the Dmp1-/-;Dspp-Tg 
mice was approximately 20-fold greater than that of the normal control. IHC revealed that, 
compared to the normal control mice (Fig. 4-1b), the long bone of the Dmp1-/- mice (Fig. 
4-1c) had weaker anti-DSP signals, while the long bone of the Dmp1-/-;Dspp-Tg mice (Fig.
4-1d) demonstrated a much stronger anti-DSP immunoreactivity than either the normal
control or the Dmp1-/- mice, consistent with the observations of the RT-qPCR analyses. In 
situ hybridization analyses showed that osteoblasts in the trabeculae immediately adjacent 
to the growth plate area had stronger signals for DSPP mRNA than the cortical bone in 
diaphysis regions. Compared to the normal controls (Fig. 4-1e), DSPP mRNA was 
downregulated in the Dmp1-/- mice (Fig. 4-1f). The Dmp1-/-;Dspp-Tg mice (Fig. 4-1g) had 
much elevated level of DSPP mRNA in the same region. These data confirmed the high 
expression level of the transgenic Dspp in the long bone of Dmp1-/-;Dspp-Tg mice.  
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Transgenic expression of Dspp lengthened the long bones of Dmp1-/- mice 
Plain X-ray radiography showed that compared to the femurs of normal 3-month-
old controls (Dmp1+/-, Fig. 4-2a), the femurs of the Dmp1-/- mice (Fig. 4-2b) were shorter 
and had wider metaphyses. The femurs of Dmp1-/-;Dspp-Tg mice  (Fig. 4-2c) were longer 
than those of the Dmp1-/- mice, with the metaphyses of the former slightly narrower than 
the latter. The density of the cortical bone in Dmp1-/-;Dspp-Tg mice also appeared higher 
than the Dmp1-/- mice, indicating a higher level of mineralization in the former than in the 
latter, which was further confirmed by micro-computed tomographic (µ-CT) analyses (see 
below). However, the femurs of the Dmp1-/-Dspp-Tg mice were notably shorter than those 
of the normal controls. At 6 months of age, the femurs of the control mice (Fig. 4-2d) were 
long and thin with parallel cortical plates; the degree of difference in the femur length 
between the Dmp1-/- mice (Fig. 4-1e) and Dmp1-/-;Dspp-Tg mice (Fig. 4-2f) was similar 
to the 3-month-old mice, with the proximal and distal metaphyses becoming much 
narrower in the latter than in the former mice. The density of the femurs in the 6-month-
old Dmp1-/-;Dspp-Tg mice, as reflected by radiopacity, was much higher than that of the 
Dmp1-/- mice at the same age, indicating that as the animal aged, the improvement of 
mineralization by the transgenic Dspp  further advanced. The quantitative analyses of the 
changes in femur length (Fig. 4-2g) showed that at 3 months of age, the average femur 
lengths of the normal control, Dmp1-/- and Dmp1-/-;Dspp-Tg mice were  15.6 mm, 11 mm 
and 12.9 mm, respectively. At 6 months of age, the average femur lengths of the normal 
control, Dmp1-/- and Dmp1-/-;Dspp-Tg mice were  17.6 mm, 13.5 mm and 15 mm, 
respectively.  The femur lengths were reduced to 70% of normal in the Dmp1-/- mice, 
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which increased to 82% of the normal in Dmp1-/-;Dspp-Tg mice at 3 months, an 11% 
increase in length. At 6 months of age, the femur length increased by 8% in Dmp1-/-;Dspp-
Tg mice compared to the Dmp1-/- mice. At either age point, the femur length differences 
between Dmp1-/-;Dspp-Tg and Dmp1-/- mice were statistically significant (P< 0.05, n = 5). 
The tails of the Dmp1-/-;Dspp-Tg mice were also longer than the those of Dmp1-/- mice but 
were shorter than the normal controls (data not shown). 
Transgenic expression of Dspp partially rescued the cortical bone defects in Dmp1-
/- mice 
The three-dimensional imaging evaluation from the low resolution micro-
computed tomographic (µ-CT) scans of whole femurs showed that the femurs of the 
normal control mice had no apparent surface porosities (Fig. 4-3a); the femurs of the 
Dmp1-/- (Fig. 4-3b) and Dmp1-/-;Dspp-Tg mice (Fig. 4-3c) had reduced length and 
demonstrated a lower mineral content as reflected by the surface porosities at 3 months of 
age. Although noticeably more porous than the normal controls (Fig. 4-3d), the femurs of 
Dmp1-/-;Dspp-Tg mice (Fig. 4-3f) had an obvious decrease in porosity at 6 months 
compared to the Dmp1-/- (Fig. 4-3e) mice. In contrast to the smooth and well-organized 
femurs of the normal control mice (Fig. 4-3g and j), the longitudinal view of the femurs 
revealed that at both 3 and 6 months of age, those of the Dmp1-/- (Fig. 4-3h and k) and 
Dmp1-/-;Dspp-Tg mice (Fig. 4-3i and l) had inner surface porosities and structural 
disorganization of the cortical bone. 
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High-resolution µ-CT scans of the cortical bone in the midshaft region of the femoral 
diaphysis were done for detailed imaging and quantitative analyses. At either 3 or 6 
months of age, the cortical layer of the Dmp1-/- mouse femurs (Fig. 4-4b and h) was 
dramatically thinner than the normal control mice (Fig. 4-4a and g). At 6 months, the 
cortical thickness of Dmp1-/-;Dspp-Tg mouse femurs (Fig. 4-4c and i) was similar to the 
normal controls. The quantification of the cortical thickness for 3-month-old (Fig. 4-4d) 
and 6-month-old (Fig. 4-4j) mice showed that the cortical thickness in the Dmp1-/-;Dspp-
Tg mice was restored to nearly the normal level at both ages. The bone volume fraction, 
expressed as the ratio of bone volume to the total volume (BV/TV), had significantly 
improved in the femurs of the Dmp1-/-;Dspp-Tg mice at 3 and 6 months of age compared 
to the Dmp1-/- mouse femurs, although the BV/TV ratios in both types of mice were lower 
than in the normal controls (Fig. 4-4e and k). When the BV/TV of the normal control mice 
was taken as 1, the BV/TV ratio of Dmp1-/- mice was lower than of the normal mice by 
23% at 3 months, while that of the Dmp1-/-;Dspp-Tg mice was lower than normal by 13%. 
At 6 months, the BV/TV ratio of Dmp1-/- mice was lower than for the normal mice by 
23%, while that of the Dmp1-/-;Dspp-Tg mice was lower by 8%. Based on these data, we 
calculated that the transgenic expression of Dspp rescued the BV/TV reduction of Dmp1-
/- mice by 42% at 3 months and 63% at 6 months. There was a significant increase in the 
apparent density and material density of the cortical bone in the Dmp1-/-;Dspp-Tg mouse 
femurs compared to those of the Dmp1-/- mice at 3 months of age (Fig. 4-4f and l). Our 
calculations revealed that the transgenic expression of Dspp rescued the apparent density 
reduction in the femurs of Dmp1-/- mice by 30% at 3 months and 45% at 6 months; it 
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corrected the material density reduction of Dmp1-/- mice by 34% at 3 months and 32% at 
6 months. Nevertheless, both the apparent density and material density of the Dmp1-
/-;Dspp-Tg mice were still significantly lower than the normal control mice at either time 
point. These findings indicated that the transgenic expression of Dspp significantly 
increased the bone volume and mineral density of cortical bone of Dmp1-/- mice.  
The trabecular thickness but not the trabecular number was significantly rescued by the 
transgenic expression of Dspp  
To analyze the trabeculae in these mice, we performed high-resolution µ-CT scans 
of the femoral distal metaphysis regions. At 3 and 6 months, the trabecular images showed 
a drastic reduction in trabecular bone in the Dmp1-/- mice (Fig. 4-5b and h)  compared to 
the control mice (Fig. 4-5a and g), which was marginally improved in the  Dmp1-/-;Dspp-
Tg mice (Fig. 4-5c and i). The quantitative analyses revealed that the number of trabeculae 
in the Dmp1-/- mice was lower than for the normal control mice by 58% at 3 months and 
53% at 6 months, while that of the Dmp1-/-;Dspp-Tg mice was lower by 53% at 3 months 
and 42% at 6 months (Fig. 4-5d and j). We calculated that the transgenic expression of 
Dspp rescued the trabecular number reduction of Dmp1-/- mice by 8% at 3 months and 
21% at 6 months. The trabecular bone thickness in the Dmp1-/- mice was greater than for 
the normal control mice by 40% at 3 months and 24% at 6 months, while that in the Dmp1-
/-;Dspp-Tg mice increased by 7% at 3 months and 2% at 6 months (Fig. 4-5e and k) 
compared to the normal control. At 6 months, the transgenic expression of Dspp near 
completely rescued the trabecular thickening defects of the Dmp1-/- mice. The trabecular 
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separation (spacing) in the Dmp1-/- mice was greater than in the normal control mice by 
149% at 3 months and 87% at 6 months, while that in the Dmp1-/-;Dspp-Tg mice had 
increased by 106% at 3 months and 57% at 6 months (Fig. 4-5f and l). For a detailed 
comparison of the bone parameters, see Tables 1 and 2 (Appendix B) The relatively lower 
level of rescue for trabecular spacing might be attributed to the limited correction of the 
trabecular bone numbers as described above (Fig. 4-5d and j).  
Transgenic expression of Dspp significantly improved the morphology and 
ultrastructure of the long bone in Dmp1-/- mice  
Hematoxylin and eosin (H&E) staining of femurs from 3-month-old mice showed 
that in comparison with the normal control mice (Fig. 4-6a), the femurs of the Dmp1-/- 
mice (Fig. 4-6b) were shorter and wider, along with presence of irregular trabeculae. There 
was a remarkably improved development of the trabecular bone network in the Dmp1-
/-;Dspp-Tg mice (Fig. 4-6c) compared to the Dmp1-/- mice. The overly-widened growth 
plate (red arrows) in the Dmp1-/- mice was reversed to a nearly normal thickness in the 
Dmp1-/-;Dspp-Tg mice. The reduced thickness of the cortical bone in the Dmp1-/- mice 
(Fig. 4-6e) was also reversed in the Dmp1-/-;Dspp-Tg mice (Fig. 4-6f) to a level similar to 
that of the normal control mice (Fig. 4-6d). Also, the cortical bone of Dmp1-/- mice (Fig. 
4-6e) had numerous areas that were hypomineralized or osteoid-like (arrow heads). To 
assess the collagen structure of the cortical bone, we performed Picrosirius red staining 
and visualized the collagen fibers under polarized light. When examined under polarized 
light, the larger collagen fibers were bright yellow or orange, and the thinner ones, 
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including reticular fibers, were green. Compared to the normal control mice (Fig. 4-6g), 
the collagen fiber network in the cortical bone of the Dmp1-/- mice (Fig. 4-6h) appeared 
disorganized and sparse. The collagen fiber organization in the femoral cortical bone of 
the Dmp1-/-;Dspp-Tg mice (Fig. 4-6i) had remarkably improved, although it was not as 
well oriented and dense as in the normal control  mice. The results of histological 
evaluation provided further support to the conclusion drawn from the µ-CT data regarding 
the restoration of cortical bone thickness and structural organization.  
To further confirm the partial rescue of the Dmp1-deficient defects by the Dspp 
transgene, we analyzed the osteocyte lacunocanalicular system of the femurs using the 
resin-casted scanning electron microscopy (SEM) approach. The osteocyte lacunae (red 
arrows) in the femurs of the normal control mice (Fig. 4-7a) were spindle-shaped, while 
the osteocyte lacunae in the Dmp1-/-mice (Fig. 4-7b) appeared enlarged, which was 
probably due to an accumulation of osteoid in the bone of these mice. The lacunae in the 
Dmp1-/-;Dspp-Tg mice (Fig. 4-7c) were smaller than those in the Dmp1-/-mice but larger 
than in the normal controls. Acid-etched SEM imaging showed that the osteocytes in the 
Dmp1-/-mice (Fig. 4-7e) exhibited a marked decrease in the number of canaliculi (red 
asterisks). The canaliculi in the long bones of the Dmp1-/-;Dspp-Tg mice (Fig. 4-7f) were 
more numerous than in the Dmp1-/-mice, but were not as well oriented as in the normal 
control mice (Fig. 4-7d). Fluorescein isothiocyanate (FITC) is a fluorescent stain that 
binds to the osteocytes and canaliculi but not to the mineralized matrix. Thus, it helps to 
visualize the unaltered cellular structure of osteocytes. The FITC staining showed well-
organized and evenly spaced osteocytes with well oriented canaliculi in the normal control 
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mice (Fig. 4-7g). The osteocytes in the Dmp1-/-mice (Fig. 4-7h) were round to ovoid and 
had a marked reduction in the number of canaliculi. The Dmp1-/-;Dspp-Tg mice (Fig. 4-
7i) exhibited smaller osteocytes than the Dmp1-/-mice with a significant rise in the number 
of canaliculi although they were not as well oriented as in the normal controls. Thus, the 
Dspp transgene partially corrected the lacunocanalicular defects of the Dmp1-deficient 
mice.  
The transgenic expression of Dspp partially corrected the altered levels of certain 
ECM molecules  
Immunohistochemistry (IHC) results confirmed the presence of DMP1 signals 
around the osteocyte lacunae and in the bone ECM of the normal control mice (Fig. 4-8a) 
and its loss in Dmp1-/- mice (Fig. 8b) and Dmp1-/-;Dspp-Tg mice (Fig. 4-8c). Biglycan is 
present in the unmineralized matrix (osteoid), and anti-biglycan IHC is often used to reveal 
osteoid [129]. The anti-biglycan IHC analyses showed remarkably increased biglycan in 
the matrix of the cortical bone of Dmp1-/- mice (Fig. 4-8e). The matrix of the Dmp1-
/-;Dspp-Tg mice (Fig. 4-8f) had much less biglycan (osteoid) than the Dmp1-/- mice, but 
more than the normal control mice (Fig. 4-8d). These findings substantiated the improved 
mineralization of the Dmp1-/-;Dspp-Tg mouse long bones. The levels of BSP, OPN and 
MEPE were higher in the long bones of the Dmp1-/- mice (Fig. 4-8h,k and n) while the 
levels of these proteins in the long bones of the Dmp1-/-;Dspp-Tg mice (Fig. 4-8i, l and o) 
were only slightly more elevated than those of the  normal control mice (Fig. 4-8g, j and 
m). Compared to the normal control mice (Fig. 4-8p), the FGF23 level was elevated in the 
45 
Dmp1-/- mice (Fig. 4-8q), and the FGF23 level in the Dmp1-/-;Dspp-Tg mice (Fig. 4-8r) 
was slightly lower than in the Dmp1-/- mice, and higher than in the normal control.  
The RT-qPCR analyses showed that the BSP mRNA level (Fig. 4-9a) was elevated 
by 9 folds while that of the OPN (Fig. 4-9b) increased to 11 folds in Dmp1-/- mice 
compared to that of the normal control. The mRNA levels of both BSP and OPN in the 
Dmp1-/-;Dspp-Tg mice were reduced to close to normal. The mRNA level of MEPE (Fig. 
4-9c), which increased to about 5 folds in Dmp1-/- mice, was restored to normal in the  
Dmp1-/-;Dspp-Tg mice. Similarly, the collagen Type 1 alpha 1 (Col1a1) expression (Fig. 
4-9d) was reduced almost to the normal level in Dmp1-/-;Dspp-Tg mice.  
The in situ hybridization analyses demonstrated relatively strong signals for 
DMP1, BSP, OPN and Col1a1 mRNAs in osteoblasts (arrows in Fig. 4-10) of the newly 
formed bone immediately subjacent to the epiphyseal growth plates in the normal mice. 
There was a complete lack of DMP1 mRNA in the Dmp1-/- (Fig. 4-10b) and Dmp1-/-;Dspp-
Tg mice (Fig. 4-10c), consistent with the immunohistochemistry results. In agreement 
with the immunohistochemistry and RT-qPCR data, the in situ hybridization analyses 
showed that compared to the normal controls (Fig. 4-10d and g), the BSP and OPN mRNA 
levels were higher in the Dmp1-/- mice (Fig. 4-10e and h), whereas the levels of these 
molecules in the Dmp1-/-;Dspp-Tg mice (Fig. 4-10f and i) were similar to those of the 
normal mice. The Col1a1 mRNA level was also higher in the Dmp1-/- mice (Fig. 4-10k) 
than in the normal controls (Fig. 4-10j), while the Col1a1 level in Dmp1-/-;Dspp-Tg mice 
(Fig. 4-10l) was similar to the normal controls.  
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Discussion 
DMP1 and DSPP share several unique similarities [48, 112, 121]. Both are cleaved 
by bone morphogenetic protein 1/tolloid-like metalloproteinases into their NH2-terminal 
and COOH-terminal fragments [75, 77, 123, 130, 131]. Their NH2-terminal fragments 
mainly exist as proteoglycans [61, 64, 99], whereas their COOH-terminal fragments are 
highly phosphorylated and promote mineralization [73, 132]. They show similar 
localization patterns in bone and tooth [133, 134]. Additionally, Dmp1-null mice and 
Dspp-null mice manifest similar dentin defects [57, 94]. These striking similarities 
between DMP1 and DSPP indicate that these two molecules may have synergistic or 
redundant roles in the formation and mineralization of hard tissues.  
While the role of DMP1 in osteogenesis has been extensively studied, the function 
of DSPP has been studied only to a limited extent. The loss of Dspp in mice leads to an 
age-related mineralization defect; however, the abnormalities in the long bone of the 
Dspp-deficient mice are mild [101]. Recently, we showed that the transgenic expression 
of DSPP completely rescued the dentin and alveolar bone defects of Dmp1-/- mice but 
failed to correct the elevated level of serum FGF23 and the reduction of serum phosphorus 
level in the Dmp1-deficient animals [105].  The in vitro luciferase assay studies by our 
group and others revealed that DMP1 enhanced the promoter activity of the Dspp gene in 
odontoblast-like cells or C3H10T1/2 mesenchymal cells transfected with DMP1-
expressing constructs [95, 105]. These findings indicate that DSPP may be a downstream 
target of DMP1 during the formation of dentin and alveolar bone. 
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In this study, we observed that the transgenic expression of Dspp led to the 
significant rescue of the long bone defects in Dmp1-null mice. While the introduction of 
transgenic Dspp into the Dmp1-deficient background led to a remarkable correction of the 
long bone defects caused by Dmp1 ablation, the impact of transgenic Dspp on different 
bone parameters reflecting various aspects of bone quality were divergent. The transgenic 
expression of DSPP rescued the bone volume reduction and hypomineralization defects 
in the cortical bone to a much greater extent than the correction of the trabecular number 
loss in the metaphysis region of Dmp1-deficient femurs. DMP1 plays broader roles than 
DSPP; the former is involved in gene regulation, FGF23 dynamics and phosphorus 
metabolism, in addition to mineralization-promoting effect, while the latter primarily 
participates in the matrix mineralization aspect of dentinogenesis and osteogenesis. The 
trabecular bone number is the most important indicator regarding the healthy status of 
trabeculae. The trabecular bones in the metaphysis region undergo faster remodeling and 
have a greater turnover rate than the cortical bone. Thus the formation of trabecular bones 
in this region may be more vulnerable to alterations of factors such as a reduction of the 
serum phosphorus level than is the cortical bone, which may be partially responsible for 
the observation that the rescue of trabecular number loss was not as significant as that of 
the cortical bones in the Dmp1-/-;Dspp-Tg mice.  
In addition to the cortical and trabecular bone changes, the partial restoration of 
the osteocyte defects by the Dspp transgenic expression was also significant. The number 
and orientation of canaliculi and the osteocyte morphology in the Dmp1-/-;Dspp-Tg mice 
showed a remarkable improvement over the Dmp1-/- mice. Our immunohistochemistry, 
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RT-qPCR and in situ hybridization analyses of BSP, OPN and MEPE showed that all these 
molecular markers were elevated in the Dmp1-/- mice, but returned to levels close to 
normal in Dmp1-/-;Dspp-Tg mice, suggesting that the osyeocyte maturation may have been 
rescued to a certain extent.  
Both DMP1 and DSPP are acidic proteins that can attract Ca2+ and promote the 
formation and growth of hydroxyapatite (HA) crystals on the collagen matrix, facilitating 
the conversion of osteoid to bone and predentin to dentin [29, 121, 127, 128, 132, 135]. 
We speculate that DSPP’s role in promoting the deposition of HA crystals as a redundant 
partner of DMP1 is the principal factor contributing to the improved quality of the long 
bone in Dmp1-/-;Dspp-Tg mice.  
 Previously, we showed that the transgenic expression of DSPP completely 
rescued the alveolar bone defects in Dmp1-null mice [105], while in this study, the same 
transgene partially rescued the long bone defects of the Dmp1-/- mice. The differences in 
the extent of the improvement between the alveolar bone and the long bone could be 
attributed to the following aspects. 1) The forming alveolar bone cells originate from the 
neural crest, which is from the ectoderm, while the osteoblasts of the long bone are from 
the mesoderm. 2) The DSPP expression level in alveolar bone is much higher than in the 
long bone [48, 136]. 3) The alveolar bone defects in Dspp-null mice [102] are much more 
severe than the long bone defects [101], suggesting that DSPP’s role in alveolar bone 
formation is more important than in the long bone. Clearly, future studies are warranted 
to elucidate the mechanisms by which the DMP1 and DSPP function differently in the 
formation of alveolar bone and long bone.  
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DSPP is proteolytically processed into NH2-terminal and COOH-terminal 
fragments. In vitro studies have revealed that the COOH-terminal fragment of DSPP 
promotes the formation and growth of HA crystals [74, 135]. In vivo studies by our group 
showed that transgenic expression of Dspp NH2-terminal fragment failed to rescue the 
dentin and alveolar bone defects in Dspp-null mice [137]. Future studies are warranted to 
define which of the individual fragments derived from DSPP is responsible for correcting 
the long bone defects of Dmp1-null mice. 
In summary, the transgenic expression of DSPP partially, but not completely, 
rescued the long bone defects of Dmp1-null mice, without a correction of serum FGF23 
elevation and  serum phosphorus reduction. DMP1 and DSPP are likely to have redundant 
roles in promoting the deposition of HA crystals during osteogenesis, which may be 
responsible for the significant improvement of long bone quality in Dmp1-/-;Dspp-Tg 
mice.   
Materials and methods  
Generation of Dmp1-/-;Dspp-Tg mice 
The generation of mice expressing a transgene encoding the full-length form of 
DSPP has been described in our previous reports [77]. In these transgenic mice, the DSPP 
transgene is downstream to the 3.6-kb rat Col 1a1 promoter that drives the expression of 
the transgene in type I collagen-expressing tissues, including bone. The transgenic mouse 
line showing the highest level of DSPP mRNA [35] in the long bone in the wild type 
background was crossbred with the Dmp1-/- mice [90, 94] to create mice that express the 
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transgenic Dspp but lack Dmp1; these mice were referred to as “Dmp1-/-;Dspp-Tg mice”. 
The genotyping approach and primers for identifying the Dmp1-null alleles and Dspp 
transgene were described previously [105]. The animal protocols related to this study were 
approved by the Animal Welfare Committee of Texas A&M University Baylor College 
of Dentistry (Dallas, TX, USA). The mice heterozygous for Dmp1 (Dmp1+/-) of 
corresponding ages were used as normal controls for all experiments as these mice do not 
manifest any developmental abnormalities compared to the wild type mice [7, 10, 14]. 
Real Time Quantitative Polymerase Chain reaction (RT-qPCR) 
The RT-qPCR analyses were performed to measure the mRNA levels of DSPP, 
BSP, OPN, MEPE and COL1a1 in the mouse long bone. Total RNA was extracted from 
the femurs of the 12-week-old mice of each group, treated with DNase I (Promega, 
Madison, WI), and purified with the RNeasy Mini Kit (Qiagen, Inc., Valencia, CA). The 
RNA (1 µg/ml per sample) was transcribed into cDNA by SuperScript III reverse 
transcriptase (Invitrogen, San Diego, CA). Specific primers and conditions used for the 
RT-qPCR analyses are listed in Table 3 (Appendix B). The housekeeping gene, 
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), was used as the internal control. 
The RT-qPCR reactions were performed using the Brilliant SYBR Green QPCR Master 
Mix (Applied Biosystems; Foster City, CA) and the CFX-96 Real-Time PCR Detection 
System (Bio-Rad; Hercules, CA). The mean values from triplicate analyses were then 
calculated and compared. 
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Plain X-ray radiography and Micro-computed tomography (μ-CT) 
The femurs from the hind limbs of 3- and 6-month-old male mice were dissected 
and analyzed with a Faxitron MX-20 specimen radiography system (Faxitron X-ray Corp., 
Buffalo Grove, IL). The measurement tool of the Faxitron software was used to measure 
the femur lengths using five femurs from five mice in each group (n = 5). The mean and 
standard deviation values from five measurements were used for quantitative comparison. 
For the μ-CT analyses, the femurs were scanned using a μ-CT 35 imaging system (Scanco 
Medical, Basserdorf, Switzerland). The μ-CT analyses included: 1) a low-resolution scan 
(7.2 μm slice increment) of the whole femur from the 3-month-old and 6-month-old male 
mice for an overall assessment of the shape and structure; 2) a high-resolution scan (3.4 
μm slice increment) of the femoral midshaft region (midway between the two epiphyses 
along the cranio-caudal axis, 200 slices) for analysis of the cortical bone in the 3-month-
old and 6-month-old male mice; 3) a high-resolution scan (3.4 μm slice increment) of the 
femoral metaphysis region proximal to the distal growth plate for evaluation of the 
trabecular bones in the 3- and 6-month-old male mice. For trabecular bone analyses, we 
selected a cylinder area in the center of the metaphysis region with a radius of 100 μm and 
a length of 1400 μm (400 slices); the cortical shell was excluded in these trabecular bone 
analyses. The cortical thickness was measured using the Scanco software, and the averages 
were obtained from five femurs of five mice in each group (n = 5). Every 20th slice from 
the high-resolution scans of the femoral midshaft region of each sample were analyzed for 
cortical thickness. The data acquired from the high-resolution scans were used for 
quantitative analyses. The quantitative μ-CT parameters obtained and analyzed using the 
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Scanco software included: ratio of bone volume to total volume (BV/TV), apparent 
density, material density, trabecular number (Tb.N), trabecular thickness (Tb.Th), and 
trabecular separation (Tb.Sp).  Six femurs from six mice in each group were used for 
quantitative analyses of BV/TV, apparent density, material density, Tb.N, Tb.Th, and 
Tb.Sp. 
Tissue preparation and histological evaluation 
Under anesthesia, the Dmp1+/-, Dmp1-/- and Dmp1-/-;Dspp-Tg mice at postnatal 6 
weeks and 3 months were perfused from the ascending aorta with 4% paraformaldehyde 
in 0.1 M phosphate-buffered saline. The femurs were dissected and further soaked in the 
same fixative for 48 h, followed by demineralization in 14% EDTA (pH 7.4) at 4°C for 2 
weeks. The tissues were processed for paraffin embedding, and serial 5-μm sections were 
prepared. The sections were stained with hematoxylin and eosin (H&E) for routine 
histology analyses; these paraffin sections were also used for immunohistochemistry and 
In situ hybridization analyses (see later). Picrosirius Red staining [138] was performed to 
assess the morphology and organization of the collagen fibrils. 
Scanning Electron Microscopy (SEM) 
The tibias of 3-month-old mice from each group were dissected and fixed in 2% 
paraformaldehyde and 2.5% glutaraldehyde in 0.1 m cacodylate buffer solution (pH 7.4) 
at room temperature. Four hours later, the samples were immersed in 0.1 m cacodylate 
solution. The samples were then dehydrated in ascending concentrations of ethanol and 
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embedded in methyl-methacrylate (MMA) resin. Microcloths with Metadi Supreme 
polycrystalline diamond suspensions of decreasing sizes (Buehler, Lake Bluff, IL) were 
used to polish the sample surfaces. The samples were coated with carbon for backscattered 
SEM analyses. For the resin-casted SEM, the samples were acid-etched with 37% 
phosphoric acid for 2–10 seconds and washed with 5.25% sodium hypochlorite for 5 
minutes. The samples were then coated with gold and palladium for secondary electron 
image analyses. A JEOL JSM-6300 scanning electron microscope (JEOL Limited, Tokyo, 
Japan) was used to perform the analyses as reported previously [91].  
Fluorescein Isothiocyanate (FITC) staining 
FITC, a small molecular dye, fills in the osteocyte lacunae and canaliculi, but does 
not stain the mineralized matrix. Thus, the dye provides a visual representation of the 
organization of the octeocytes and their lacunocanalicular system under a confocal 
microscope [139]. The tibias from each group of 3-month-old mice were dissected and 
dehydrated through a series of ethanol solutions from 70–100% and acetone solution, 
followed by 1% FITC stain (Sigma-Aldrich, St. Louis, MO) overnight, with additional 
dehydration and MMA embedding as described above. A cross section (500 µm thick) 
from the tibial midshaft region was cut with a diamond-bladed saw (Buehler), and the 
plastic sections were then sanded and ground to a final thickness of 30-50 µm for confocal 
imaging using the Leica SP2 confocal microscope (Leica TCS, Germany). 
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Immunohistochemistry (IHC) and generation of monoclonal anti-FGF23 antibody 
 For the immunohistochemistry analyses, anti-DSP-2C12.3 monoclonal antibody 
[115] was used at a concentration of 2.05 µg/ml. Anti-DMP1 monoclonal antibody that 
recognizes the C-terminal region of DMP1 [134, 136] was used at a concentration of 4.7 
µg/ml. Anti-biglycan polyclonal antibody LF-159 [140] was used at a dilution of 1:1000. 
Anti-BSP monoclonal antibody 10D9.2 [118] was used at a concentration of 4.5 µg/ml. 
Polyclonal anti-OPN antibody [141] was used at a dilution of 1:400. Anti-MEPE 
polyclonal antibody (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) was used at a 
concentration of 2.1 µg/ml.  
Recently, we generated anti-FGF23 monoclonal antibodies which recognize both 
human and mouse FGF23. Briefly, five BALB/c mice were immunized with the full-
length human recombinant FGF23 using a Bac-to-Bac baculovirus expression system 
(Invitrogen) as we previously reported [142], and the immunization boosting was given 
every 3 weeks for a total of four times (Creative Biolabs, Shirley, NY). The titers of serum 
anti-FGF23 antibodies were determined with an enzyme-linked immunosorbent assay. 
One of the five mice that showed the highest titer for the anti-FGF23 activity was given a 
final boosting and sacrificed for cell fusion; the splenocytes from this mouse were fused 
with FO murine myeloma cells. The fusion cells showing positive reactions to FGF23 
were screened with the Omni Hybridoma Platform (Creative Biolabs) and cloned. After 
testing 207 single clones, we obtained 15 positive clones. Western immunoblotting 
analyses in our laboratory revealed that the cultural media (supernatants) from three 
positive clones (hybridoma cell lines) including Clone 79 showed strong reactions to both 
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human and mouse FGF23. Clone 79 with the IgG isotype was expanded in syngeneic 
mice; the ascites were collected from these mice and the “anti-FGF23-79 antibody” was 
isolated from the ascites by HiTrap rProtein A FF (Creative Biolabs). We further 
confirmed the immunoreactivity of purified anti-FGF23-79 antibody to both human and 
mouse recombinant FGF23 by Western immunoblotting analyses. Our IHC analyses with 
long bone samples from Dmp1+/- and Dmp1-/- mice revealed that anti-FGF23-79 antibody 
gave rise to highly specific signals in the osteocyte lacunae and the matrices around 
osteocytes, and the anti-FGF23 immunoreactivity was remarkably stronger in the Dmp1-/- 
mouse bone than in the Dmp1+/- mouse bone. The anti-FGF23-79 antibody at 2.75 µg/ml 
concentration was used for IHC analyses in the current study. 
All the IHC experiments were carried out using the mouse on mouse kit for 
monoclonal antibodies and the ABC kit for polyclonal antibodies (Vector Laboratories, 
Burlingame, CA).  The 3, 3′-diaminobenzidine (DAB) kit (Vector Laboratories) was used 
for color development according to the manufacturer’s instructions. 
In situ hybridization 
In situ hybridization was performed to assess the mRNA levels of DSPP, DMP1, 
BSP, OPN and COL1a1 in the femurs of 6-week-old mice for each group. Detailed 
information regarding the RNA probes for DSPP [127], DMP1 [127], BSP [143], OPN 
[143] and COL1a1 [91] has been described previously. The RNA probes were labeled 
with digoxigenin using a RNA labeling kit (Roche, Indianapolis, IN) and were detected 
by an enzyme-linked immunoassay with a specific anti-digoxigenin-alkaline phosphatase 
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antibody conjugate and alkaline phosphatase substrate (Roche), following the 
manufacturer’s instructions. Nuclear fast red was used for counterstaining.  
Statistical analysis 
The data analyses were performed with a one-way analysis of variance for multiple 
group comparisons. If significant differences were found with the one-way analysis of 
variance, the Bonferroni method was used to determine which groups were significantly 
different from others. The quantified results were expressed as the mean ± S.D.  P≤ 0.05 
was considered to be statistically significant.   
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CHAPTER V 
CONCLUSION 
A multitude of studies have focused on the mineral-matrix relationship in bones 
and teeth. Dentin and bone are complex structures that consist of hydroxyapatite crystals 
deposited in an orchestrated manner on an organic matrix scaffold. In organic phase of 
ECM of these hard tissues, Noncollagenous proteins (NCPs) are found tightly associated 
with collagen. Among the NCPs, the SIBLING family of proteins are the most widely 
studied. DSPP, a member of the SIBLING family, is the most abundant NCP present in 
the ECM of dentin. In dentin and bone, DSPP is mainly present as the processed amino 
(NH2) terminal (including DSP and DSP-PG) and carboxy (COOH) terminal fragment, 
DPP. Despite of being derived from the same gene and protein precursor, their 
biochemical properties of DSP and DPP are very different. DSP is rich in sialic acid, is a 
glycoprotein and has few or no phosphate groups [37, 144]. It shares overall characteristics 
with the other sialoproteins, Osteopontin and Bone sialoprotein. DPP is the most abundant 
NCP in the ECM of dentin, accounting for as much as 50% of the NCPs [69]. DPP contains 
a large number of aspartic acid (Asp) and serine (Ser) residues [24, 70]. The repeating 
sequences of aspartic acid and phosphorylated serine make DPP highly acidic and negative 
which fits well with its function in the hydroxyapatite crystal growth and formation.  
There are a total of 36 novel DSPP mutations reported so far that cause inherited 
dentin defects [46]. These mutations are transmitted in an autosomal dominant pattern and 
fall into two groups. In both cases, the mutant protein is retained in the rough endoplasmic 
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reticulum (rER) and hence fails to effectively traffic out of the cell [145]. Dspp null mice 
display severe tooth defects due to widened predentin and dentin hypomineralization [57], 
which closely mimic the signs of human DGI type III. Expression of DSPP in odontoblasts 
is reported to be higher during primary dentinogenesis than during secondary 
dentinogenesis, suggesting DSPP plays more significant role during odontoblast 
differentiation and primary dentinogenesis [146].  
Along with its established role in tooth formation, DSPP has also been identified 
in bone, cementum and several non-mineralized tissues. Its expression in alveolar bone 
and cementum is remarkably higher than in the long bone [110]. DSP and DPP, the two 
cleaved fragments of DSPP, are the active forms essential for its function during 
dentinogenesis [114]. In the first study, we analyzed the periodontium of mice expressing 
the mutated DSPP transgene [114] to examine whether mutated DSPP (in which Aspartic 
acid, was replaced by Alanine at position 452) or normal-DSPP could rescue the 
phenotypes observed in alveolar bone and cementum of Dspp-KO mice.  Transgenic 
expression of normal DSPP was able to rescue the alveolar and cementum phenotypes in 
Dspp-KO mice, but the mutated DSPP transgene failed to do so. Thus, during 
dentinogenesis, the cleavage of DSPP is an activation step, essential for the development 
and maintenance of the periodontium.  This study suggests that the function of DSPP may 
be mediated by its processed fragments. However, the proteolytic processing of DSPP 
gives rise to three fragments: DSP, DSP-PG and DPP, each of these may have a specific 
role in the periodontal tissues. The N-terminal fragment of DSPP (DSP and DSP-PG) may 
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have an inhibitory effect on dentinogenesis [87]. It is therefore necessary to find out the 
roles played by each of these fragments in hard tissues.   
The phenotype of Dspp-KO mice helps us understand the significance of DSPP, 
however, the individual roles of DSP or DPP in dentin mineralization remain elusive. In 
the periodontal structures, DSPP was found in the osteocytes of the alveolar bone, 
cementocytes of cellular cementum in the apical region as well as in the matrices 
surrounding these mineralized tissue-forming cells [110]. DSPP has been shown to play 
an essential role in periodontal tissue formation [102]. Dspp-KO mice had severe alveolar 
bone loss with reduced cementum deposition and altered osteocyte morphology. 
Transgenic mice, in which only DSP is expressed in a Dspp-KO background have been 
generated utilizing the Col1a1 promoter[104]. In the second study, we analyzed the 
specific role of the NH2-terminal fragment of DSPP in periodontium, using transgenic 
mice overexpressing this fragment. We found that, in comparison to Dspp-KO mice, mice 
overexpressing the NH2-terminal fragment of DSPP had severe inflammatory infiltration 
around the alveolar bone, significantly reduced osteocyte processes, greater reduction of 
interradicular and interdental bone, greater loss of cellular cementum, and more severe 
migration of junctional epithelium towards the apex. A recent report has demonstrated that 
DSP can act as a ligand and binds to integrin β6 [147]. Immunoprecipitation assays 
revealed that integrin β6 was bound by the 112 amino acid residues aa183-295 of DSP, 
protein-protein interaction assays indicated that only 36 amino acid residues of the DSP 
domain aa183-219 could bind to integrin β6. The NH2-terminal fragments of DSPP exist 
as two forms: DSP and DSP-PG [64]. The exact ratio of DSP to DSP-PG is unknown, 
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however, it is reported that DSP-PG is a major proteoglycan in the dentin matrix [61, 62, 
64]. In this study, the worsening of periodontal defects of Dspp-KO mice overexpressing 
the NH2 terminal fragment, indicates that the NH2-terminal fragment of this protein may 
play an inhibitory role in the formation and mineralization of hard tissues in the 
periodontium.  However, future studies are warranted to define which of the two NH2-
terminal forms is exerting these inhibitory functions. 
Dspp-KO mice displayed only subtle changes in the long bone, most likely because 
of its lower expression in bone as compared to dentin [101]. DPP is clearly important for 
undifferentiated mesenchymal and osteoblastic cells to differentiate into mature 
odontoblasts and/or osteoblasts [148]. By activation of the MAPK pathway recombinant 
DPP is able to induce osteogenic differentiation in osteoblastic cells and mesenchymal 
stem cells [149, 150]. In the same study, DPP stimulated phosphorylation of Smad-1 and 
induced expression of osteoblastic and odontoblastic differentiation markers. This 
suggests that DPP activates Smad-1 via integrin signaling independently of BMP signaling 
[151].  
Function of DSPP in osteogenesis has been studied only to a limited extent. 
Transgenic expression of DSPP completely rescued the dentin and alveolar bone defects 
of Dmp1-null mice but failed to correct their altered serum FGF23 and phosphate levels 
[105]. Dmp1 enhanced the promoter activity of the Dspp gene in odontoblast-like cells or 
mesenchymal cells in vitro [95, 105]. This means that DSPP may be a downstream target 
of DMP1 during the formation of dentin and alveolar bone. 
61 
In our third study, we observed that the transgenic expression of DSPP led to the 
significant rescue of the long bone defects in Dmp1-null mice. While the introduction of 
transgenic DSPP into the Dmp1-deficient background led to a remarkable correction of 
the long bone defects caused by Dmp1 deletion, the impact of transgenic DSPP on 
different bone parameters was different. The transgenic expression of DSPP rescued the 
bone hypomineralization defects in the cortical bone to a much greater extent than the 
correction of the trabecular bone defects in Dmp1-deficient mice. DMP1 has been shown 
to play broader in gene regulation, phosphate metabolism, in addition to mineralization-
promoting effect, while DSPP has only been reported to participate in mineralization 
aspect of dentinogenesis and osteogenesis. In addition to the cortical and trabecular bone 
changes, the partial restoration of the osteocyte defects by the DSPP transgenic expression 
was also significant. A recent report showed recombinant DSP upregulates type I collagen 
and DSPP expression in non-odontogenic osteoblasts, induces bone formation in ex vivo 
bone culture, at least in part by stimulating osteoblast cell growth and differentiation 
levels, thereby providing a mechanism for DSP induced anabolic effects on bone [152]. 
A vital number of questions regarding DSPP still need to be addressed. The role 
of the proteoglycan form of N-terminal fragment (DSP-PG) is yet to be elucidated. Does 
the N-terminal fragment facilitate DSPP protein folding and/or secretion? Why are these 
biochemically and functionally diverse fragments transcribed from the same gene. Minute 
quantity of full-length DSPP has been isolated from bone and dentin recently, however 
it’s unclear if it is the remainder of the uncleaved fragments or if it plays a specific function 
[153, 154]. Regulatory mechanisms for the gene expression of DSPP Still need to be 
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further studied. Also, DMP-1 directly induced DSPP gene expression and DSPP 
overexpression compensated for lack of DMP1 in mice and rescued the dentin defects 
completely and long bone defects partially [89, 95, 105]. Thus, DMP1 and DSPP may 
have synergistic roles not only during dentinogenesis, but also during osteogenesis. In 
order to answer these questions, studies on intracellular transport of DSPP, its precursor 
synthesis, and transport to ECM via the ER and golgi apparatus need to be studied in 
detail. A complete understanding of these mechanisms can help us elaborate the basic 
understanding of mineralization process during dentinogenesis and osteogenesis and can 
lead to development of new biomedical applications for alleviating mineralized tissue 
diseases.  
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APPENDIX A 
FIGURES 
Figure 1-1 Deintin sialophosphoprotein gene structure: The Dentin 
sialophosphoprotein gene consiste of 5 exons and 4 introns. Exon 1 is non-coding. The 
second exon codes the signal peptide. The NH2-terminal fragment arises from the exons 
2, 3, 4 and 5’ end of exon 5. The C-terminal fragment is encoded from exon 5. DSP, Dentin 
Sialoprotein; DSP-PG, proteoglycan form of DSP; DPP, Dentin phosphoprotein. 
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Figure 1-2 Generation and characterization of the D452A-DSPP Tg mice: To examine 
the in vivo effects of the NH2-terminal fragment of DSPP on biomineralization we 
generated a strain of Col 1a1-VSV-DSP mice that express the NH2-terminal fragment of 
DSPP in the Dspp-KO background. In the transgenic mice, the DSP transgene is driven 
by a type I collagen promoter (Col 1A1). The rationale for using the Col 1A1 promoter to 
drive the DSP transgene include: 1) this promoter works properly in driving the expression 
of genes that are active in bone and/or dentin; 2) a high expression level of the DSP 
transgene in the bone will allow us to study the role of this protein in osteogenesis since 
under physiological conditions the expression of DSPP (DSP) in bone is very low. The 
targeting vector used for the generation of the transgenic mice contains rat Col 1A1 
promoter plus intron of the rat Col 1A1 gene, mouse Dspp signal peptide, three VSV 
epitopes and the cDNA sequence encoding the NH2-terminal portion of mouse DSPP. 
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Figure 2-1 Failure to process DSPP into fragments leads to alveolar bone defects. 
H&E staining of alveolar bone at both 3- and 6-months of age, showed that the Dspp-KO 
(D and H) and Dspp-KO/D452A-Tg mice (B and F) had significant alveolar bone loss in 
the furcation region of the first mandibular molar with inflammation (black arrows), 
compared to the WT mice (A and E). The transgenic expression of normal DSPP (C and 
G, Dspp-KO/normal-Tg mice) completely  rescued the alveolar bone defects of Dspp-KO 
mice;  the alveolar bone Dspp-KO/normal-Tg mice (C and G) appeared similar to those 
of the WT mice (A and E).  Bar: 100 μm 
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Figure 2-2 Quantitative μ-CT analyses. The quantitative μ-CT analyses of alveolar bone 
in the 3-month (A) and 6-month (B) old mice showed that transgenic expression of normal 
DSPP transgene was able to reverse the bone volume fraction of Dspp-KO mice at both 
ages to a level comparable to WT mice. There was no significant difference between the 
bone volume fraction of the WT and Dspp-KO/normal-Tg mice (a). The Dspp-
KO/D452A-Tg mice showed no significant improvement over Dspp-KO mice at either 
age (b). P < 0.05 was considered significant; different letters above each bar indicate a 
significant difference (Student's t-test, p < 0.05); data represent mean ± SD and n = 5.  
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Figure 2-3 Failure to process DSPP into fragments leads to loss of epithelium 
attachment in the interdental region. At 3- and 6-months of age, H & E staining showed 
that the interdental epithelial attachment between the first and second mandibular molars 
of the WT (A and E) and Dspp-KO/normal-Tg mice (C and G) was at the cemento-enamel 
junction (CEJ) (indicated with a black arrow), whereas the Dspp-KO (D and H) and Dspp-
KO/D452A-Tg mice (B and F) showed alveolar bone loss with an apically recessed 
epithelial attachment (black arrows denote the CEJ; red arrows indicate the actual 
epithelial attachment). Bar: 100 μm.  
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Figure 2-4 Failure to process DSPP into fragments leads to decreased cementum 
deposition. In these backscattered SEM (A-D) and resin-casted SEM (E-H) images, the 
dentin is denoted as “D”; pulp as “P” and cementum as “C”.  In the backscattered SEM 
images, the black areas represent unmineralized or hypomineralized areas. Therefore, the 
pulpal space appears as black (denoted as P); Cementum (C) is less mineralized than 
Dentin (D) and appears darker than dentin. The Dspp-KO (D) and Dspp-KO/D452A-Tg 
mice (B) showed increased black areas periapically indicating decreased cementum 
deposition compared to the WT (A) and Dspp-KO/normal-Tg mice (C).  The resin-casted 
SEM gave a better visualization of the periapical region of cementum.. The WT (E) and 
Dspp-KO/normal-Tg mice (G) showed a thick layer of cementum deposition at the root 
apex whereas; Dspp-KO (H) and Dspp-KO/D452A-Tg mice (F) showed little or no 
cementum in the same region.  Bar: 200 μm. 
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Figure 3-1 Inflammatory infiltration and furcation bone loss. H&E staining for the 
furcation regions of the first mandibular molars from 3-month-old WT (A), Dspp KO (B) 
and Dspp KO/DSP Tg (C) mice.  While the inflammatory reaction (black arrows in B and 
C) was present in the molar furcation region of both Dspp KO and Dspp KO/DSP Tg mice,
the inflammation in the latter mice was more remarkable than in the former.  Note that
there was very little alveolar bone left in the molar furcation region of Dspp KO/DSP Tg
mice. Bar: 100 μm.
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Figure 3-2 Migration of epithelial attachment in the periodontium. H&E staining for 
the interdental regions between the first and second molars of mandibles in the 3-month-
old WT (A), Dspp KO (B) and Dspp KO/DSP Tg (C) mice. Black arrows indicate the 
cemento-enamel junctions. Blue arrows indicate the site of the epithelial attachment 
(bottom of the gingival sulcus).  The reduction of the interdental alveolar bone in the Dspp 
KO/DSP Tg (C) was greater than in the Dspp KO mice. The epithelial attachment receded 
more apically in the Dspp KO/DSP Tg mice (C, indicated by blue arrow) than in the Dspp 
KO mice. Bar: 100 μm. 
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Figure 3-3 Quantitative analysis of reduction of alveolar bone. The quantitative μ-CT 
analyses of the interradicular alveolar bone in the 3-month-old (A) and 6-month-old (B) 
mice. Student’s t-test was used to statistically compare the mean differences between two 
groups in each of the paired analyses. The differences in the bone volume fractions 
(BV/TV) between the Dspp KO and Dspp KO/DSP Tg mice at both ages were statistically 
significant. The data represent mean ± SD (n = 3). BV, bone volume; TV, total volume; 
*: P ≤ 0.05. 
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Figure 3-4 SEM imaging of cementum. Backscattered SEM (A-C) and resin-casted SEM 
analyses for the periapical regions of first molars in the mandibles of 3-month-old WT (A, 
D), Dspp KO (B, E) and Dspp KO/DSP Tg (C, F) mice. In these SEM images, the dentin 
is denoted as ‘D’, pulp as ‘P’, and cementum as ‘C’. In the backscattered SEM images, 
the black areas represent unmineralized or hypomineralized areas, and thus, the dental 
pulp (P) appears black.  Cementum (C) is less mineralized (appears darker) than dentin 
(D). In comparison with the WT mice (A), the periapical regions of Dspp KO (B) and 
Dspp KO/DSP Tg (C) mice had broader areas of blackness in the backscattered SEM 
images and contained smaller areas of cementum.  Among the three types of mice, Dspp 
KO/DSP Tg mice had the least amounts of cellular cementum. The resin-casted SEM 
images (D-F) also revealed that among the three groups, the Dspp KO/DSP Tg mice (F) 
had the least amounts of cellular cementum in the periapical region. Bar: 200 μm.  
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Figure 3-5 Alteration of the osteocyte morphology. Resin-casted SEM analyses of the 
osteocyte lacunae and canaliculi in the alveolar bone of 3-month-old WT (A), Dspp KO 
(B) and Dspp KO/DSP Tg (C) mice. In the WT mice the canaliculi radiated out in
directions perpendicular to the long axis of the osteocyte bodies.  In contrast, the osteocyte
lacunae in the alveolar bone of the Dspp KO and Dspp KO/DSP Tg mice appeared
irregular with disorganized and fewer canaliculi.  The defects of the osteocyte lacunae and
the structures surrounding the lacunae in the alveolar bone of Dspp KO/DSP Tg mice were
apparently worse than those of the Dspp KO mice.  Bar: 5 μm.
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Figure 4-1 Expression of Dspp transgene. a, RT-qPCR analyses; b-d, 
immunohistochemistry staining using the anti-DSP antibody; e-g, in situ hybridization 
analyses for DSPP mRNA. In the RT-qPCR analyses (a), we measured the mRNA levels 
of DSPP in the femurs of 3-month-old mice from each group. The DSPP mRNA level in 
the normal control (Dmp1+/-) mice (green bar) was taken as 1. DSPP mRNA level in the 
Dmp1-/- mice (red bar) was 30% of the normal mice, while its level in the Dmp1-/-;Dspp-
Tg mice (blue bar) was 20 fold of the normal. The anti-DSP immunostaining exhibited 
signals for this protein around the osteocyte lacunae in the cortical bone in the mid-shaft 
region of the femurs of control mice (b). The anti-DSP signals were slightly weaker in the 
cortical bone of Dmp1-/- mice (c) than in the normal controls.  The cortical bone of Dmp1-
/-;Dspp-Tg mice (d) demonstrated a higher level of anti-DSP immunoreactivity compared 
to the other two groups of mice. In situ hybridization analyses show the presence of DSPP 
mRNA (arrows) in the newly formed bone proximal to the epiphyseal growth plate of 
normal controls (e); DSPP mRNA level was lower in Dmp1-/- mice (f) than in the normal 
control. In the same region, Dmp1-/-;Dspp-Tg mice (g) showed elevated level of DSPP 
mRNA confirming the higher expression levels of Dspp transgene in these mice. Scale 
bar: 50 µm in b-g. 
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Figure 4-2 Plain X-ray radiography of femurs from the three groups of mice at the 
ages of 3 and 6 months. At 3 months, the femurs of the normal control (Dmp1+/-) mice 
(a) had parallel and uniform cortical layers throughout the diaphysis of the bone and the
metaphysis regions were slightly wider than the shaft. The femurs of the 3-month-old
Dmp1-/- mice (b) and Dmp1-/-;Dspp-Tg mice (c) were shorter and wider than those of the
normal control, and showed significant outward protrusion (irregular enlargement) in the
metaphysis regions, particularly in the distal metaphysis areas.  At 6 months, the length
difference between the normal control mice (d) and Dmp1-/- mice (e) became greater. Both
the distal and proximal metaphysis regions of 6-month-old Dmp1-/- mice (e) and Dmp1-
/-;Dspp-Tg mice (f) showed apparent enlargement. At either 3 or 6 months, the femurs of
Dmp1-/-;Dspp-Tg mice (c, f) were longer than those of the Dmp1-/- mice (b, e).
Quantitative analyses (g) showed the differences in average femur length between the
Dmp1-/-;Dspp-Tg and Dmp1-/- mice at 3 months (12.94 mm vs. 11.08 mm) and 6 months
(15.1 mm vs. 13.5 mm) were statistically significant. P < 0.05 (Student's t-test) was
considered significant. Data represent mean ± SD (n = 5). When the letters above two bars
are different, the difference between the two groups was statistically significant (P < 0.05).
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Figure 4-3 Micro-computed tomography (µ-CT) analyses of femurs from 3- and 6-
month-old mice. a-f: full views of the femurs at lower resolution; g-l: longitudinal-section 
views of the femurs at lower resolution. Full views of the whole femurs revealed that at 
both ages, the femurs of the normal control mice (a, d) had a smooth surface while those 
of the Dmp1-/- (b, e) and Dmp1-/-;Dspp-Tg (c, f) mice showed a porous appearance. 
Longitudinal-section views demonstrated that compared to the normal control (g, j), the 
inner surfaces of the femur shells of the Dmp1-/- (h, k) and Dmp1-/-;Dspp-Tg (i, l) mice 
were rougher.  At either 3 or 6 months, the bone in the Dmp1-/-;Dspp-Tg mice appeared to 
have fewer surface porosities than in the Dmp1-/- mice in both the full and longitudinal-
section views. Scale bar: a to l = 500 µm 
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Figure 4-4 High resolution imaging and quantitative µ-CT analyses of cortical bone. 
a-c: high resolution views of the cortical mid-shaft regions of femurs at 3 months; g-i:
high resolution views of the cortical mid-shaft regions of femurs at 6 months. At both
ages, the cortical bone in the mid-shaft region was thinner in the Dmp1-/- mice (b, h) than
in the normal controls (a, g), while the femur thickness of Dmp1-/-;Dspp-Tg mice (c, i)
was similar to that of Dmp1+/- mice. Scale bars: 100 µm in all images. The quantitative
analyses of the cortical thickness validated the imaging result at 3 months (d) and 6 months
(j) of ages; the cortical thickness in Dmp1-/-;Dspp-Tg mice was restored to a level similar
to that of the normal control. The bone volume fraction (BV/TV) in the diaphyseal mid-
shaft region in the femurs of Dmp1-/-;Dspp-Tg mice was significantly greater than in the
Dmp1-/- mice; at 6 months, the improvement of BV/TV in the Dmp1-/-;Dspp-Tg mice was
more remarkable (e, k). The bone density represented by the density of total volume
(Apparent Density) and density of bone volume (Material Density) was significantly
reduced in Dmp1-/- mice compared to the normal controls at 3 months (f) and 6 months
(l). The transgenic expression of Dspp significantly improved the apparent and material
densities at 3 months. At 6 months, the apparent density of the Dmp1-/-;Dspp-Tg mice  was
significantly higher than in Dmp1-/- mice, but the change in the material density was not
statistically significant. P < 0.05 (Student's t-test) was considered significant. Data
represent mean ± SD (n = 5 for d and j; n = 6 for e, f, k and l). Different letters above two
bars indicate a significant difference (P < 0.05) between the two groups.
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Figure 4-5 High resolution imaging and quantitative µ-CT analyses of trabecular 
bone. a-c: high resolution views of the distal metaphysis regions at 3 months; g-i: high 
resolution views of the distal metaphysis regions at 6 months. High resolution images of 
the distal metaphysis regions showed that in comparison with the normal controls (a, g), 
Dmp1-/- mice (b, h) and Dmp1-/-;Dspp-Tg mice (c, i) had a remarkable reduction in 
trabecular bone number. Scale bars: 100 µm in all images. Colored scale bars indicate the 
trabecular thickness ranging from 0.00 mm (blue) to 0.07 mm (red). Quantitative analyses 
revealed that at 6 months (j), but not at 3 months (d), the trabecular number was 
significantly higher in the Dmp1-/-;Dspp-Tg mice than in Dmp1-/- mice. The most 
remarkable change of trabeculae in Dmp1-/-;Dspp-Tg mice was the restoration of 
trabecular thickness to nearly normal level at both ages (e, k). The spacing between the 
trabeculae in Dmp1-/-;Dspp-Tg mice, at both 3 months (f) and 6 months (l), although not 
completely reduced to the normal level of control mice, was significantly lower than that 
of Dmp1-/- mice. P < 0.05 (Student's t-test) was considered significant. Data represent 
mean ± SD (n = 6 for d-l). Different letters above two bars indicate a significant difference 
(P < 0.05) between the two groups 
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Figure 4-6 Histological analyses of the femurs from 3-month-old mice. a-f: H&E 
staining; the images in the middle row are higher magnification views of boxed areas in 
the upper row; g-i: Picrosirius red staining of the cortical bone in the mid-shaft region of 
the femurs. The growth plate (red arrows) was wider and cortical bone was thinner in the 
Dmp1-/- mice (b) than in the normal control (a) or Dmp1-/-;Dspp-Tg mice (c). The cortical 
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Fig. 4-6 Continued: 
bone in the Dmp1-/- mice (e) appeared to have more hypomineralized areas or osteoid areas 
(stained grey, indicated by arrowheads) than in the normal control (d) or the Dmp1-/-;Dspp-
Tg mice (f). Picrosirius red staining, which specifically stains collagen, showed that while 
the cortical bone of normal control mice (g) had well-organized fibrillary network with 
fewer large (yellow/orange) fibers and more reticular (green) fibers. The collagen network 
was highly disorganized in Dmp1-/- mice (h) with obvious reduction in the reticular fibers. 
Dmp1-/-;Dspp-Tg mice (i) showed a notable improvement in collagen fibril organization. 
Scale bars: 500 µm in a-c; 100 µm in d-f; 50 µm in g-i 
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Figure 4-7 Scanning electron microscopy (SEM) analyses of the femurs from 3-
month-old mice. a-c: Backscatered SEM imaging of cortical bone from midshaft region 
of tibia; d-f: acid-etched SEM imaging of cortical bone from midshaft region of tibia; g-i: 
FITC staining of cortical bone from the same region. The backscattered SEM imaging 
showed spindle-shaped osteocyte lacunae that were well organized and well oriented in 
the bone of normal control mice (a). The cortical bone of Dmp1-/- mice (b) and Dmp1-
/-;Dspp-Tg mice (c) showed fewer and disoriented osteocyte lacunae. The acid etched 
SEM analyses revealed that the osteocytes in the normal control mice (d) were narrow 
with many osteocyte processes in the canaliculi that were running perpendicular to the cell 
bodies. The osteocyte lacunae in Dmp1-/-;Dspp-Tg mice (f) were slightly more enlarged 
and ovoid with fewer canaliculi than the in normal mice, but were smaller than the rounded 
lacunae in Dmp1-/- mice (e) that had lost nearly all of the canaliculi. FITC staining showed 
the lacunocanalicular system was well organized with numerous canaliculi in the normal 
control mice (g). Dmp1-/- mice (h) had a remarkable reduction in the number of canaliculi 
while the Dmp1-/-;Dspp-Tg mice (i) showed a partial restoration in the number of 
canaliculi.  Scale bars in a-c: 20 µm; in d-f: 5 µm; in g-i: 10 µm. 
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Figure 4-8 Immunohistochemical analyses of the femurs from 3-month-old mice. All 
of the images were from the mid-shaft region of the femurs.  Immunohistochemistry 
against DMP1 (a-c) showed that the normal control mice (a) demonstrated positive anti-
DMP1 signals in the cortical bone, which were relatively stronger around the osteocyte 
lacunae, whereas there was a complete loss of signals for this molecule in  Dmp1-/- mice 
(b) and Dmp1-/-;Dspp-Tg mice (c). Immunohistochemistry against biglycan (d-f), which 
often serves to reflect the amount of osteoid in the bone matrix, showed that compared to 
the normal control mice (d), the femurs of Dmp1-/- mice (e) had much more biglycan. The 
level of biglycan in Dmp1-/-;Dspp-Tg mice (f) was remarkably lower than in the Dmp1-/-
mice but slightly higher than in the normal control mice. The signals for BSP, OPN and 
MEPE were increased in Dmp1-/- mice (h, k, n), compared to the normal controls (g, j, m), 
while the levels of the these proteins in Dmp1-/-;Dspp-Tg mice (i, l, o) were comparable 
to the normal control mice. FGF23 level was increased in Dmp1-/- mice (q), compared to 
the normal control mice (p). FGF23 level was slightly reduced in Dmp1-/-;Dspp-Tg mice 
(r) compared to the Dmp1-/- mice. Scale bars: 50 µm in all images.
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Figure 4-9 Real Time Quantitative PCR (RT-qPCR) analyses. RT-qPCR analyses of 
RNA samples from the femurs of 3-month-old mice showed that compared to the normal 
control, Dmp1-/- mice  had an approximately 9 fold increase of BSP mRNA level (a); in 
Dmp1-/-;Dspp-Tg mice, BSP mRNA level  was about 2 fold of the normal. The changes 
of OPN mRNA levels (b) showed a similar pattern. The mRNA level of MEPE (c) in 
Dmp1-/- mice was 5 fold over normal, while it was restored completely back to normal in 
Dmp1-/-;Dspp-Tg mice. Col1a1 mRNA levels (d) were restored close to normal in Dmp1-
/-;Dspp-Tg mice. 
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Figure 4-10 In Situ hybridization analyses. In situ hybridization showed the presence 
of DMP1 mRNA in the osteoblasts (arrows) of newly formed trabecular bone immediately 
subjacent to the growth plate in the normal control mice (a). The Dmp1-/- mice (b) and 
Dmp1-/-;Dspp-Tg mice (c) had a complete lack of signals for DMP1. The same region of 
Dmp1-/- mouse femurs (e, h) had elevated levels of BSP and OPN mRNA, compared to 
the normal control (d, g). The BSP and OPN mRNA levels in Dmp1-/-;Dspp-Tg mice (f, i) 
were similar to the normal controls. Col1a1 mRNA level was higher in Dmp1-/- mice (k), 
which was also reduced in Dmp1-/-;Dspp-Tg mice (l), to a level similar to the Dmp1+/- mice 
(j). Scale bar: 50 µm in all images. 
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APPENDIX B 
TABLES  
Dmp1+/- Dmp1-/- Dmp1-/-;Dspp-Tg 
BV/TV .94250 .72962 .81946 
Std. Deviation .0161 .073 .026 
Material Density (mgHA/cm3) 1092.82 957.53 1006.40 
Std. Deviation 40.75 26.37 18.55 
Apparent Density (mgHA/cm3) 1029.71 712.41 806.81 
Std. Deviation 43.38 39.64 36.87 
Trabecular Number 5.334 2.234 2.487 
Std. Deviation .5880 .2546 .3951 
Trabecular Thickness (mm) .040 .056 .043 
Std. Deviation .0065 .0047 .0017 
Trabecular spacing (mm) .1934 .4815 .3980 
Std. Deviation .019 .031 .036 
Table 1. Bone parameters at 3 months 
100 
Table 2. Bone parameters at 6 months 
Dmp1+/- Dmp1-/- Dmp1-/-;Dspp-Tg 
BV/TV .9405 .7254 .8630 
Std. Deviation .0158 .0453 .0494 
Material Density (mgHA/cm3) 1127.46 1009.05 1047.41 
Std. Deviation 34.39 45.38 32.27 
Apparent Density (mgHA/cm3) 1059.88 783.71 908.83 
Std. Deviation 25.88 79.18 47.11 
Trabecular Number 4.421 2.070 2.554 
Std. Deviation .5794 .5167 .4778 
Trabecular Thickness (mm) .041 .051 .042 
Std. Deviation .0057 .0089 .0082 
Trabecular spacing (mm) .2833 .5310 .4442 
Std. Deviation .025 .146 .0495 
101 
Table 3. Primer sequences used for Real Time quantitative PCR 
Gene Primer sequences Produ
ct size 
Tm 
(°C) 
Dspp Forward: 5′-AACTCTGTGGCTGTGCCTCT-3′ 
Reverse: 5′-TATTGACTCGGAGCCATTCC-3′ 
171 59 
Bsp Forward: 5′-AAAGTGAAGGAAAGCGACGA-3′ 
Reverse: 5′-GTTCCTTCTGCACCTGCTTC-3′ 
215 52 
Opn Forward: 5′-TCTGATGAGACCGTCACTGC-3′ 
Reverse: 5′-AGGTCCTCATCTGTGGCATC-3′ 
170 53 
Mepe Forward: 5′-CTGTGGATCCTTGTGAGAAT-3′ 
Reverse: 5′-TAGAGGATTTTGGCTTTCTG-3′ 
199 55 
Col1α1 Forward: 5′-CCTGACGCATGGCCAAGAAGA-3′ 
Reverse: 5′-GCATTGCACGTCATCGCACA-3′ 
145 60 
Gapdh Forward: 5′-CAAAGTTGTCATGGATGACC-3′ 
Reverse: 5′-CCATGGAGAAGGCTGGGG-3′ 
195 56 
(Note: Tm – Melting Temperature) 
